0001692427-21-000007 | 10-K | XBRL Viewer | NCS Multistage Holdings INC

Cost of product sales and services, exclusive of depreciation and amortization expense shown below

$ 106,977

$ 205,485

$ 226,963

Cost of sales

62,907

108,030

108,306

Selling, general and administrative expenses

59,425

88,554

82,813

Depreciation

4,426

5,877

4,747

Amortization

1,465

4,559

13,090

Change in fair value of contingent consideration

(2,872)

Impairments

50,194

7,919

227,543

Loss from operations

(71,440)

(9,491)

(206,664)

Other income (expense)

Interest expense, net

(1,796)

(1,925)

(1,963)

Gain on patent infringement settlement

25,678

Other income, net

1,729

308

182

Foreign currency exchange (loss) gain

(1,060)

(958)

162

Total other income (expense)

24,551

(2,575)

(1,619)

Loss before income tax

(46,889)

(12,066)

(208,283)

Income tax (benefit) expense

(7,783)

10,752

(23,052)

Net loss

(39,106)

(22,818)

(185,231)

Net income attributable to non-controlling interest

18,493

10,005

5,086

Net loss attributable to NCS Multistage Holdings, Inc.

$ (57,599)

$ (32,823)

$ (190,317)

Loss per common share

Basic loss per common share attributable to NCS Multistage Holdings, Inc. (in dollars per share)

^[1]

$ (24.37)

$ (14.08)

$ (85.00)

Diluted loss per common share attributable to NCS Multistage Holdings, Inc. (in dollars per share)

^[1]

$ (24.37)

$ (14.08)

$ (85.00)

Weighted average common shares outstanding

Basic

^[1]

2,364

2,332

2,239

Diluted

^[1]

2,364

2,332

2,239

Product sales [Member]

Revenues

Cost of product sales and services, exclusive of depreciation and amortization expense shown below

$ 75,197

$ 145,826

$ 156,781

Cost of sales

46,647

75,081

74,892

Services [Member]

Revenues

Cost of product sales and services, exclusive of depreciation and amortization expense shown below

31,780

59,659

70,182

Cost of sales

$ 16,260

$ 32,949

$ 33,414

[1]	Amounts in 2019 and 2018 have been retrospectively adjusted for the 1-for-20 reverse stock split that was effective on December 1, 2020.

CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals)	12 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals)	Dec. 31, 2020
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Reverse stock split, description	1-for-20

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]
Net loss	$ (39,106)	$ (22,818)	$ (185,231)
Foreign currency translation adjustments, net of tax of $0	(969)	3,219	(17,323)
Comprehensive loss	(40,075)	(19,599)	(202,554)
Comprehensive income attributable to non-controlling interest	18,493	10,005	5,086
Comprehensive loss attributable to NCS Multistage Holdings, Inc.	$ (58,568)	$ (29,604)	$ (207,640)

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References + Details

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References + Details

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

Beginning balance at Dec. 31, 2017

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]
Foreign currency translation adjustments, tax	$ 0	$ 0	$ 0

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands

Preferred Stock [Member]

Common Stock [Member]

Additional Paid-In Capital [Member]

Accumulated Other Comprehensive Loss [Member]

Retained Earnings (Deficit) [Member]

Adoption of ASC 606 [Member]

Retained Earnings (Deficit) [Member]

Treasury Stock [Member]

Non-controlling Interest [Member]

Adoption of ASC 606 [Member]

Total

$ 22

^[1]

$ 399,843

^[1]

$ (66,707)

$ 247

$ 23,864

$ (175)

$ 12,144

$ 247

$ 368,991

Beginning balance, shares at Dec. 31, 2017

2,196,574

^[1]

Beginning balance, Treasury Stock, shares at Dec. 31, 2017

^[1]

(917)

Share-based compensation

10,930

^[1]

10,930

Distribution to noncontrolling interest

(190,317)

5,086

(185,231)

(2,300)

Exercise of stock options

1,079

^[1]

1,079

Exercise of stock options, shares

^[1]

34,513

Vesting of restricted stock, shares

^[1]

1,836

Shares withheld

$ (162)

(162)

Shares withheld, shares

^[1]

(498)

Cemblend exchangeable shares, shares

^[1]

22,115

Currency translation adjustment

(17,323)

Ending balance at Dec. 31, 2018

$ 22

^[1]

411,852

^[1]

(84,030)

(166,206)

$ (337)

14,930

176,231

Ending balance, shares at Dec. 31, 2018

2,255,038

^[1]

Ending balance, Treasury Stock, shares at Dec. 31, 2018

^[1]

(1,415)

Share-based compensation

12,204

^[1]

12,204

Distribution to noncontrolling interest

(32,823)

10,005

(22,818)

(6,000)

Vesting of restricted stock, shares

^[1]

10,320

Shares withheld

$ (315)

(315)

Shares withheld, shares

^[1]

(3,218)

Cemblend exchangeable shares

^[1]

$ 1

(1)

Cemblend exchangeable shares, shares

(1)

66,347

^[1]

Proceeds from the issuance of ESPP

1,024

^[1]

1,024

Proceeds from the issuance of ESPP, shares

^[1]

13,584

Currency translation adjustment

3,219

Ending balance at Dec. 31, 2019

$ 23

^[1]

425,079

^[1]

(80,811)

(199,029)

$ (652)

18,935

$ 163,545

Ending balance, shares at Dec. 31, 2019

^[1]

2,345,289

Ending balance, Treasury Stock, shares at Dec. 31, 2019

(4,633)

^[1]

(4,633)

Share-based compensation

7,723

^[1]

$ 7,723

Distribution to noncontrolling interest

(57,599)

18,493

(39,106)

(17,550)

Exercise of stock options, shares

^[1]

675

Vesting of restricted stock

^[1]

$ 1

(1)

Vesting of restricted stock, shares

^[1]

26,028

Shares withheld

$ (157)

(157)

Shares withheld, shares

^[1]

(7,441)

Currency translation adjustment

(969)

Ending balance at Dec. 31, 2020

$ 24

^[1]

$ 432,801

^[1]

$ (81,780)

$ (256,628)

$ (809)

$ 19,878

$ 113,486

Ending balance, shares at Dec. 31, 2020

^[1]

2,371,992

Ending balance, Treasury Stock, shares at Dec. 31, 2020

(12,074)

^[1]

(12,074)

[1]	Amounts in 2019 and 2018 have been retrospectively adjusted for the 1-for-20 reverse stock split that was effective on December 1, 2020.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parentheticals)	12 Months Ended
	Dec. 31, 2020
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY [Abstract]
Reverse stock split, description	1-for-20

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities
Net (loss) income	$ (39,106)	$ (22,818)	$ (185,231)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	5,891	10,436	17,837
Impairments	50,194	7,919	227,543
Amortization of deferred loan cost	296	312	334
Share-based compensation	8,482	12,542	10,930
Provision for inventory obsolescence	1,820	895	1,673
Deferred income tax (benefit) expense	(3,202)	9,000	(28,840)
(Gain) loss on sale of property and equipment	(592)	(312)	74
Write-off of deferred loan costs	606
Gain on patent infringement settlement	(25,678)
Change in fair value of contingent consideration		37	(2,872)
Provision for doubtful accounts	750	3,500	304
Net proceeds from patent infringement settlement	21,370
Payment of contingent consideration		(3,042)
Proceeds from note receivable	302
Changes in operating assets and liabilities:
Accounts receivable—trade	19,250	4,735	(4,213)
Inventories, net	3,241	(7,639)	(2,949)
Prepaid expenses and other assets	(3,022)	488	(624)
Accounts payable—trade	(3,170)	2,580	219
Accrued expenses	(105)	(681)	(2,430)
Other liabilities	534	(1,606)	(620)
Income taxes receivable/payable	(2,744)	1,603	(17,109)
Net cash provided by operating activities	35,117	17,949	14,026
Cash flows from investing activities
Purchases of property and equipment	(2,098)	(6,123)	(11,134)
Purchase and development of software and technology	(55)	(251)	(4,675)
Proceeds from sales of property and equipment	1,094	1,372	399
Net cash used by investing activities	(1,059)	(5,002)	(15,410)
Cash flows from financing activities
Equipment note borrowings		835	1,988
Payments on equipment note and finance leases	(1,513)	(5,021)	(2,422)
Promissory note borrowings			5,360
Payments on promissory note			(8,673)
Payments on revolver	(15,000)	(10,000)
Payment of contingent consideration		(6,958)
Line of credit borrowings	5,000
Payment of deferred loan cost related to senior secured credit facility	(553)	(871)
Proceeds from the exercise of options for common stock, net			1,079
Treasury shares withheld	(157)	(315)	(162)
Distribution to non-controlling interest	(17,550)	(6,000)	(2,300)
Proceeds from the issuance of ESPP shares		1,024
Net cash used by financing activities	(29,773)	(27,306)	(5,130)
Effect of exchange rate changes on cash and cash equivalents	17	471	(2,164)
Net change in cash and cash equivalents	4,302	(13,888)	(8,678)
Cash and cash equivalents beginning of period	11,243	25,131	33,809
Cash and cash equivalents end of period	15,545	11,243	25,131
Supplemental cash flow information
Cash paid for interest, net of amounts capitalized	929	1,070	1,373
Cash paid for income taxes (net of refunds)	(1,924)	122	22,356
Noncash investing and financing activities
Return of vehicles under finance lease	(798)
Leased assets obtained in exchange for new finance lease liabilities	5,305	1,383	2,603
Leased assets obtained in exchange for new operating lease liabilities	2,572	328
Changes in accounts payable related to capital expenditures	$ (184)	$ (599)	$ 783

Organization and Basis of Presentation	12 Months Ended
Organization and Basis of Presentation	Dec. 31, 2020
Organization and Basis of Presentation [Abstract]
Organization and Basis of Presentation	Note 1. Organization and Basis of Presentation Organization NCS Multistage Holdings, Inc., a Delaware corporation, through its wholly owned subsidiaries and subsidiaries for which it has a controlling voting interest (collectively referred to as the “Company,” “NCS,” “we,” “our” and “us”), is primarily engaged in providing engineered products and support services for oil and natural gas well completions and field development strategies. We offer our products and services primarily to exploration and production companies for use in onshore wells. We operate through service facilities principally located in Houston and Odessa, Texas; Tulsa, Oklahoma; Billings, Montana; Morgantown, West Virginia; Calgary, Red Deer, Grande Prairie and Estevan, Canada; Neuquén, Argentina and Stavanger, Norway. Basis of Presentation Our accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). All intercompany transactions have been eliminated in consolidation. As NCS has the controlling voting interest in Repeat Precision, LLC (“Repeat Precision”), the other party’s ownership percentage is presented separately as a non-controlling interest. Certain reclassifications have been made to conform 2019 balances to our 2020 presentation on the consolidated balance sheets. Reverse Stock Split and Authorized Share Reduction On December 1, 2020, NCS implemented a reverse stock split of our shares of common stock in a ratio of 1-for-20 (the “reverse stock split”) with no reduction in the shares of preferred stock outstanding, and no change in the par value of the common and preferred stock. Unless specified otherwise, all common stock share amounts disclosed in this Annual Report on Form 10-K (“Form 10-K”) referencing a period prior to the reverse stock split have been adjusted to reflect this reverse stock split for all periods presented. In addition, our certificate of incorporation was amended to decrease our authorized capital stock to consist of 11,250,000 shares of common stock. Our authorized shares of preferred stock remained 10,000,000 shares. See “Note 12. Stockholders’ Equity” for additional information.

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2020

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates include but are not limited to estimated losses on accounts receivables, estimated realizable value on excess and obsolete inventories, estimates related to fair value of reporting units for purposes of assessing possible goodwill impairment, expected future cash flows from long lived assets to support impairment tests, share based compensation, amounts of deferred taxes and income tax contingencies. Actual results could materially differ from those estimates.

COVID-19 Pandemic Impacts

Coronavirus disease 2019 (“COVID-19”), an infectious disease caused by severe acute respiratory syndrome coronavirus 2, has spread globally. The World Health Organization declared the COVID-19 outbreak a public health emergency of international concern on January 30, 2020 and a pandemic on March 11, 2020.

As the impact of the pandemic continues to evolve, estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require judgment. These estimates and assumptions may change in future periods and will be recognized in the consolidated financial information as new events occur and additional information becomes known. To the extent actual results differ materially from those estimates and assumptions, our future financial statements could be affected.

Foreign Currency

Our functional currency is the United States Dollar (“USD”). The financial position and results of operations of our significant foreign subsidiaries are generally measured using the local currency as the functional currency. In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 830, Foreign Currency Matters, revenues and expenses of the significant foreign subsidiaries have been translated into USD at average exchange rates prevailing during the period. Assets and liabilities have been translated at the rates of exchange on the consolidated balance sheet date. The resulting translation gain and loss adjustments have been recorded directly as a separate component of other comprehensive (loss) in the accompanying consolidated statements of comprehensive (loss) income, and changes in stockholders’ equity.

Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations as incurred.

Revenue Recognition

We derive our revenues primarily from highly engineered products and support services. Revenues are based upon a purchase order, contract or other persuasive evidence of an arrangement with the customer that includes a fixed or determinable price, provided that collectability is reasonably assured, but such arrangements do not generally include right of return or other similar provisions or other significant post-delivery obligations. Sales and value added taxes that we collect concurrent with revenue-producing activities are excluded from revenue. We recognize revenue through the following steps: (i) identify the contract, (ii) identify the performance obligations, (iii) determine the transaction price, (iv) allocate the transaction price and (v) satisfy the performance obligation.

On occasion, we issue credits to our customers that are related specifically to the performance of our products or the services we provide, with such credits reducing the amount of revenue for the completed sales. These credits are infrequent, situation specific and cannot be individually estimated in advance.

The payment terms and conditions in our customer contracts vary. We do not have contracts that contain a financing component and do not accept noncash consideration from customers.

NCS has elected to recognize shipping and handling costs when control of the product transfers to the customer. These costs are included in cost of sales in our consolidated statements of operations.

Product Sales Revenues

For product sale arrangements that are standard inventory products or modified inventory products with an alternative use, revenue is recognized at a point in time when control transfers. Control generally transfers upon shipment or delivery, and delivery is based on the customer instructions. Customers may also request bill and hold arrangements in writing. Once we have completed the bill and hold order, the products are segregated from the rest of inventory in the warehouse. The transaction price for product sales having a performance obligation is the price per unit times the unit quantity ordered and shipped to the customer or consumed at the well site.

Services Revenues

For service arrangements that do not have a contract provision with a right to a payment for services up to the date of termination, revenue is recognized when the job has been completed, which usually includes a customer signature or acknowledgement and when there are no additional services or future obligations required by us. The transaction price is determined by the contract unit day rate times the cumulative number of days of service provided upon the completion of the service and upon customer acceptance.

For service arrangements that do have a contract provision with a right to payment for services up to the date of termination, revenue is recognized over time using a unit rate (labor and materials) output method that corresponds to the value we would receive upon termination of the contract at a reporting period. In applying the output method at the end of a quarter, we check that there is no material work in progress that is not in the measurement of the output. The transaction price for the period end is determined by the contract unit rate times the cumulative number of units earned up to the reporting period less any revenue recognized in prior periods.

Cash and Cash Equivalents

We consider all highly liquid instruments purchased with an original maturity date of three months or less to be cash equivalents. These items are carried at cost, which approximates fair value.

In accordance with ASC 230, Statements of Cash Flow, cash flows from our significant foreign subsidiaries are calculated based on our functional currency. As a result, amounts related to changes in assets and liabilities reported in the consolidated statements of cash flows will not necessarily agree to changes in the corresponding balances on the consolidated balance sheets.

Concentration of Credit Risk

Financial instruments that potentially subject us to credit risk are cash and cash equivalents and trade accounts receivable. Cash balances are maintained in financial institutions which, at times, exceed federally insured limits. We monitor the financial condition of the financial institutions in which the accounts are maintained and have not experienced any losses in such accounts.

Substantially all of our sales are to customers whose activities are directly or indirectly related to the oil and gas industry. We generally extend credit to these customers and, therefore, collectability of receivables is affected by market conditions in the oil and gas industry. We perform ongoing credit evaluations as to the financial condition of our customers with respect to trade accounts receivables. Generally, no collateral is required as a condition of sale.

For the year ended December 31, 2020, there was one customer that accounted for 10% or more of the total revenue. We recognized revenue from this customer totaling $10.2 million, or 10% of 2020 total revenue for the year ended December 31, 2020. No single customer individually accounted for 10% or more of our consolidated revenue during 2019 and 2018. One customer accounted for 12% and 10% of our trade accounts receivable balance as of December 31, 2020 and 2019, respectively.

Accounts Receivable, Trade and Allowance for Doubtful Accounts

Trade accounts receivable are recorded at their invoiced amounts and do not bear interest. We perform ongoing credit evaluations of our clients and monitor collections and payments.

We maintain an allowance for doubtful accounts for estimated losses that may result from the inability of our customers to make required payments. Earnings are charged with a provision for doubtful accounts based on a current review of the collectability of customer accounts by management. Such allowances are based upon several factors including, but not limited to credit approval practices, industry and customer historical experience as well as the current and projected financial condition of the specific customer. Accounts deemed uncollectible are applied against the allowance for doubtful accounts. As of December 31, 2020 and 2019, we have recorded $0.6 million and $0.5 million, respectively, in our allowance for doubtful accounts.

Inventories

Inventories consist primarily of raw material, product components, assembled products, certain components used to internally construct our frac isolation assemblies, and chemicals used in our tracer diagnostics services in raw materials or finished goods. Inventories are stated at the lower of cost or estimated net realizable value. Cost is determined at standard costs approximating the first-in, first-out or average cost basis. We continuously evaluate inventories, based on an analysis of inventory levels, historical sales experience and future sales forecasts, to determine obsolete, slow-moving and excess inventory. Adjustments to reduce such inventory to its estimated recoverable value have been recorded as an adjustment to cost of sales.

Impairments

We evaluate our property and equipment and finite-lived intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Should the review indicate that the carrying value is not fully recoverable, the amount of the impairment loss is determined by comparing the carrying value to the estimated fair value. We assess recoverability based on undiscounted future net cash flows. Estimating future net cash flows requires us to make judgments regarding long-term forecasts of future revenues and costs related to the assets subject to review. These forecasts are uncertain in that they require assumptions about our revenue growth, operating margins, capital expenditures, future market conditions and technological developments. If changes in these assumptions occur, our expectations regarding future net cash flows may change such that a material impairment could result. For the year ended December 31, 2020, we recognized an impairment charge of $50.2 million related to property and equipment and identified intangible assets. There was no impairment of property and equipment and finite-lived intangible assets during the year ended December 31, 2019. For the year ended December 31, 2018, we recognized an impairment charge of $73.5 million related to identifiable intangible assets. There was no impairment related to property and equipment in 2018. See “Note 6. Property and Equipment” and “Note 7. Goodwill and Identifiable Intangibles” included herewith for further information related to these charges.

An assessment of potential goodwill impairment indicators is performed annually or when there is an indication an impairment may have occurred. We typically complete our annual impairment test for goodwill using an assessment date in the fourth quarter of each fiscal year. Under GAAP, we have the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of one or more of our reporting units is greater than its carrying amount. If, after assessing the totality of events or circumstances, we determine it is more likely than not that the fair value of a reporting unit is greater than its carrying amount, there is no need to perform any further testing. However, if we conclude otherwise, then we are required to perform a quantitative impairment test by calculating the fair value of the reporting unit and comparing this value with the carrying value of the reporting unit. We also have the option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. The fair value of the reporting unit is determined using a combination of a market multiple and a discounted cash flow approach. Determining the fair value of a reporting unit requires the use of estimates, assumptions and judgment. The principal estimates and assumptions that we use include revenue growth, operating margins, capital expenditures, future market conditions, weighted average costs of capital, a terminal growth rate, the set of comparable companies utilized, and the earnings metrics and multiples utilized. We believe that the estimates and assumptions used in impairment assessments are reasonable. If the fair value of the reporting unit is less than the carrying amount, an impairment charge is recorded in the amount of the difference. No impairment charge was recorded for the year ended December 31, 2020. We recorded an impairment charge of $7.9 million and $154.0 million for the years ended December 31, 2019 and 2018, respectively. For additional information, see “Note 7. Goodwill and Identifiable Intangibles”.

Property and Equipment

Property and equipment are stated at historical cost adjusted for impairment, less accumulated depreciation. Equipment held under finance leases are stated at the present value of minimum lease payments at inception of the lease, less accumulated depreciation. Expenditures for property and equipment and for items which substantially increase the useful lives of existing assets are capitalized at cost and depreciated over their estimated useful life utilizing the straight-line method. Routine expenditures for repairs and maintenance are expensed as incurred. Depreciation is calculated over the estimated useful lives of the related assets using the straight-line method. Leasehold improvements and property under finance leases are amortized over the shorter of the remaining lease term or useful life of the related asset. Depreciation expense includes amortization of assets under finance leases. The cost and related accumulated depreciation of assets retired or otherwise disposed of are eliminated from the accounts, and any resulting gains or losses are recognized in the year of disposal as a component of other income, net.

Depreciation on property and equipment, including assets held under finance leases, is calculated using the straight-line method over the following useful service lives or lease term (which includes reasonably assured renewal periods):



	Years
Buildings	30
Building equipment and leasehold improvements	1-15
Machinery and equipment and service equipment	5-12
Computers and software	3-5
Furniture and fixtures	3-5
Vehicles	2-4
Right of use assets - finance leases	Lease term (3-10)

Business Combinations, Goodwill and Intangible Assets

Business combinations are accounted for under the acquisition method of accounting in accordance with FASB ASC 805, Business Combinations. Under the acquisition method of accounting, the total consideration transferred in connection with the acquisition is allocated to the tangible and intangible assets acquired, liabilities assumed, and any non-controlling interest in the acquiree based on their fair values. Goodwill acquired in connection with business combinations represents the excess of consideration transferred over the net tangible and identifiable intangible assets acquired. Certain assumptions and estimates are employed in evaluating the fair value of assets acquired and liabilities assumed. These estimates may be affected by factors such as changing market conditions, technological advances in the oil and natural gas industry or changes in regulations governing that industry. The most significant assumptions requiring judgment involve identifying and estimating the fair value of intangible assets and the associated useful lives for establishing amortization periods. To finalize purchase accounting for significant acquisitions, we utilize the services of independent valuation specialists to assist in the determination of the fair value of acquired intangible assets.

Costs related to the acquisition, other than those associated with the issuance of debt or equity securities, that we incur in connection with a business combination are expensed as incurred.

Any contingent consideration payable is recognized at fair value at the acquisition date. Liability-classified contingent consideration is remeasured each reporting period with changes in fair value recognized in earnings until the contingent consideration is settled.

All identifiable intangibles are amortized on a straight-line basis over the estimated useful life or term of related agreements. Deferred loan costs are amortized to interest expense using the effective interest method. Certain costs incurred in the development of internal-use software applications are capitalized and costs incurred outside of the software application development stage are expensed as incurred. The amounts capitalized are included in intangible assets, categorized as internally developed software, and are amortized on a straight-line basis over the estimated useful life of the software when ready for the intended use. These assets are tested for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.

Income Taxes

We are taxed as a corporation as defined under the Internal Revenue Code. The liability method is used in accounting for deferred income taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when these differences are expected to reverse. The realizability of deferred tax assets is evaluated annually and a valuation allowance is provided if it is more likely than not that the deferred tax assets will not give rise to future benefits. We follow guidance in ASC 740, Income Taxes, for uncertainty in income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the consolidated financial statements. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the consolidated financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. A valuation allowance to reduce deferred tax assets is established when it is more likely than not that some portion or all the deferred tax assets will not be realized. We recognize accrued interest and penalties related to uncertain tax positions in other income, net on the consolidated statements of operations.

Share-Based Compensation

We account for our stock-based compensation awards in accordance with ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). To measure the grant-date fair value of share-based compensation, we use the market price of our common stock for equity-classified restricted stock units (“RSUs”) and equivalent stock units, or cash-settled, liability-classified RSUs (“ESUs”), the Black-Scholes model for options and a Monte Carlo simulation for the performance stock unit awards (“PSUs”). We measure all share-based compensation awards at fair value on the date they are granted and recognize the compensation expense in the financial statements over the requisite period and record forfeitures as they occur. As the ESUs will be settled in cash, the compensation cost is remeasured each reporting period at fair value based upon the closing stock price of our common stock until the awards are settled.

We also have an Employee Stock Purchase Plan (the “U.S. ESPP”) and an employee stock purchase plan specifically applicable to non-U.S. employees on substantially the same terms as the ESPP (the “Non-U.S. ESPP” and together with the U.S. ESPP, the “ESPP”), which allows eligible employees to purchase shares of our common stock. The purchase price of the stock is 85% of the lower of the stock price at the beginning or end of the plan period. The fair value of the employees’ purchase rights under the ESPP is also estimated using the Black-Scholes model. The ESPP was temporarily suspended for future offering periods beginning on July 1, 2019.

Fair Value

The carrying amounts for financial instruments classified as current assets and current liabilities approximate fair value due to the short maturity of such instruments. The book values of other financial instruments, such as our debt under our senior secured revolving credit facility, approximates fair value because interest rates charged are comparable to other financial instruments with similar terms and maturities and the rates vary in accordance with a market index consistent with ASC 820, Fair Value Measurements.

For the financial assets and liabilities disclosed at fair value, fair value is determined as the exit price, or the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The established fair value hierarchy divides fair value measurement into three broad levels:

Level 1—inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date;

Level 2—inputs other than quoted prices included within Level 1 that are observable for the assets or liability, either directly or indirectly; and

Level 3—inputs are unobservable for the asset or liability, which reflect the best judgment of management.

The financial assets and liabilities that are disclosed at fair value for disclosure purposes are categorized in one of the above three levels based on the lowest level input that is significant to the fair value measurement in its entirety. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.

Severance and Other Termination Benefits

We accrue one-time severance costs pursuant to an approved workforce reduction plan at the communication date, when affected employees have been notified of the potential severance and sufficient information has been provided for the employees to calculate severance benefits, in the event the employee is involuntarily terminated. During 2020, we recorded $5.7 million of severance expense associated with one-time severance cost, of which a liability of $0.7 million remained at December 31, 2020.

Earnings Per Share

Basic income per share is calculated by dividing net income (loss) attributable to NCS Multistage Holdings, Inc. by the weighted-average number of common shares outstanding during the period. The diluted income per share computation is calculated by dividing net income (loss) attributable to NCS Multistage Holdings, Inc. by the weighted-average number of common shares outstanding during the period, taking into effect, if any, shares that would be issuable upon the exercise of outstanding stock options, unvested RSUs and PSUs and purchases under the ESPP, reduced by the number of shares purchased by us at cost, when such amounts are dilutive to the income per share calculation.

Research and Development

Research and development costs are incurred both through engaging third parties to perform development activities under our coordination and management as well as through the utilization of our employees to create and develop new ideas and products. We incurred approximately $1.9 million, $2.8 million and $3.8 million in research and development costs for the years ended December 31, 2020, 2019 and 2018, respectively. These costs are recorded in selling, general and administrative (“SG&A”) expenses on the consolidated statements of operations. Occasionally a customer may contract us to provide research and development of a product, for which we are compensated. We recognize the revenue when the project is completed and accepted by the customer, and record the corresponding research and development costs as cost of goods sold.

Recent Accounting Pronouncements

Pronouncements Adopted in 2020

In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other-Internal-Use Software (Subtopic 350-40). The ASU aligns the requirements to capitalize implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements to capitalize implementation costs incurred to develop or obtain internal-use software. For public entities, this guidance became effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption was permitted, including adoption in any interim period. We adopted ASU No. 2018-15 on a prospective basis on January 1, 2020, with no material impact on our consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820). The ASU modifies, removes and adds certain disclosure requirements on fair value measurements. For public entities, this guidance became effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption was permitted for all amendments. Alternatively, entities could early-adopt certain eliminated or modified disclosure requirements and delay the adoption of all new disclosure requirements until the effective date. We adopted ASU No. 2018-13 on January 1, 2020, with no material impact on our consolidated financial statements.

Pronouncements Not Yet Effective

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848). The ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for contracts, hedging relationships, and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or other interest rates used globally that could be discontinued. The amendments are effective for all entities as of March 12, 2020 through December 31, 2022. We are currently evaluating the impact of the adoption of this guidance.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU No. 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. For public entities, this guidance is effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. We are currently evaluating the impact of the adoption of this guidance.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326). This ASU introduces a new impairment model that is based on expected credit losses rather than incurred credit losses for financial instruments, including trade accounts receivable. It requires an entity to measure expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. The new standard was to become effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. In November 2019, the FASB issued ASU 2019-10, which deferred the effective dates for certain accounting guidance (ASUs). The effective date for ASU No. 2016-13 will remain the same for public business entities that are Securities and Exchange Commission (“SEC”) filers, except for entities who are deemed smaller reporting companies (“SRC”). The effective date for all other entities, including SRCs, will begin after December 15, 2022 and interim periods within those fiscal years. NCS qualifies as a SRC. We are currently evaluating the impact of the adoption of this guidance.

Revenues

12 Months Ended

Dec. 31, 2020

Revenues [Abstract]

Note 3. Revenues

Disaggregation of Revenue

We sell our products and services primarily in North America and in selected international markets. Revenue by geography is attributed based on the current billing address of the customer. See “Note 18. Segment and Geographic Information” for our disaggregated revenue by geographic area.

Contract Balances

When the timing of the delivery of products and provision of services is different from the timing of the customer payments, we recognize either a contract asset (performance precedes contractual due date in connection with estimates of variable consideration) or a contract liability (customer payment precedes performance) on our consolidated balance sheet. We currently do not have any contract assets or non-current contract liabilities. The following table includes the current contract liabilities as of December 31, 2020, 2019 and 2018 (in thousands):


Balance at December 31, 2018	$	515
Additions		104
Revenue recognized		(560)
Balance at December 31, 2019	$	59
Additions		—
Revenue recognized		(8)
Balance at December 31, 2020	$	51

Our contract liability as of December 31, 2020 and 2019 is included in current liabilities on our consolidated balance sheet. Generally, the performance obligations for our product and service revenues are satisfied before the customer’s payment is received. However prepayments may occasionally be required for international sales. Revenue recognized from the contract liability balance was $8 thousand, $0.6 million and $0.5 million for the years ended December 31, 2020, 2019 and 2018, respectively.

Contracts with Multiple Performance Obligations

Approximately 99% of our product and service revenues are considered a single performance obligation. Our self-service product line, which is approximately one percent of our revenue for the years ended December 31, 2020, 2019 and 2018 is made up of two performance obligations: (i) the delivery of tracer materials to a customer well site and (ii) the creation of diagnostic reports ordered by customers when we do not perform an integrated service. For these contracts, we do not allocate the transaction price as the individual performance obligations are sold at standalone prices in the customer order. The transaction prices for our self-service product line that have two performance obligations are (i) the price per unit times the quantity of tracer materials and (ii) prices charged for diagnostic reports ordered by and delivered to the customer.

Practical Expedients

We generally expense sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within SG&A expenses on the consolidated statements of operations.

We do not disclose the value of unsatisfied performance obligations when the related contract has a duration of one year or less or we recognize revenue equal to what we have the right to invoice when that amount corresponds directly with the value to the customer of our performance to date.

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Other Current Receivables [Abstract]

Inventories, Net

12 Months Ended

Dec. 31, 2020

Inventories, Net [Abstract]

Inventories, Net

Note 4. Inventories, net

Inventories consist of the following as of December 31, 2020 and 2019 (in thousands):


	December 31,		December 31,
	2020		2019
Raw materials	$	1,752	$	1,986
Work in process		287		523
Finished goods		32,832		37,412
Total inventories, net	$	34,871	$	39,921

Other Current Receivables

12 Months Ended

Dec. 31, 2020

Other Current Receivables

Note 5. Other Current Receivables

Other current receivables consist of the following as of December 31, 2020 and 2019 (in thousands):


	December 31,		December 31,
	2020		2019
Current income tax receivables	$	6,295	$	4,777
Employee receivables		544		5
Other receivables		1,519		246
Total other receivables, net	$	8,358	$	5,028

Employee receivables relate primarily to amounts paid by us for foreign withholding tax paid on behalf of employees working on international assignments, which is expected to be reimbursed to us by the employees when refunded as foreign tax credits on home-country tax returns.

Property and Equipment

12 Months Ended

Dec. 31, 2020

Property and Equipment [Abstract]

Property and Equipment

Note 6. Property and Equipment

Property and equipment by major asset class consist of the following as of December 31, 2020 and 2019 (in thousands):



	December 31,		December 31,
	2020		2019
Land	$	1,695	$	2,090
Building and improvements		8,511		12,242
Machinery and equipment		18,211		21,469
Computers and software		2,374		2,694
Furniture and fixtures		1,150		1,208
Vehicles		442		646
Right of use assets - finance leases		8,020		5,739
Service equipment		244		244
		40,647		46,332
Less: Accumulated depreciation and amortization		(16,312)		(14,333)
		24,335		31,999
Construction in progress		100		975
Property and equipment, net	$	24,435	$	32,974

The following table presents the depreciation expense associated with the following income statement line items for the years ended December 31, 2020, 2019 and 2018 (in thousands):


	Year Ended December 31,
	2020		2019		2018
Cost of sales
Cost of product sales	$	1,679	$	2,711	$	2,003
Cost of services		1,043		1,266		1,070
Selling, general and administrative expenses		1,704		1,900		1,674
Total depreciation	$	4,426	$	5,877	$	4,747

We lease land and a building in addition to vehicles for our transportation fleet, which are included in the table above. See “Note 15. Leases”.

We evaluate our property and equipment for impairment whenever changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. We performed an impairment analysis to assess the recoverability of the carrying values for our property and equipment during the first quarter of 2020 because we determined that a triggering event had occurred. Evidence that led to a triggering event included the industry conditions, such as a reduction in global economic growth expectations, a significantly reduced demand for crude oil and refined products, the significant decline in commodity prices and the corresponding impact on future expectations of demand for our products and services primarily related to the COVID-19 pandemic as well as the resulting decline in the quoted price of our common stock. As a result of the analysis, we recorded an impairment charge of $9.7 million in our property and equipment, primarily related to our land, building and improvements and machinery and equipment, because the carrying value exceeded the estimated fair value as of March 31, 2020. We did not identify any triggering events after March 31, 2020 through December 31, 2020 that required further impairment testing. Therefore, we have not recorded any impairment charges since March 31, 2020. No impairment charges associated with our property and equipment were recorded for the years ended December 31, 2019 and 2018.

Goodwill and Identifiable Intangibles

12 Months Ended

Dec. 31, 2020

Goodwill and Identifiable Intangibles [Abstract]

Goodwill and Identifiable Intangibles

Note 7. Goodwill and Identifiable Intangibles

Changes in the carrying amount of goodwill is as follows (in thousands):



	Gross Value		Accumulated Impairment		Net
Balance at December 31, 2018	$	177,115	$	(154,003)	$	23,112
Impairments		—		(7,937)		(7,937)
Currency translation adjustment		47		—		47
Balance at December 31, 2019	$	177,162	$	(161,940)	$	15,222
Impairments		—		—		—
Balance at December 31, 2020	$	177,162	$	(161,940)	$	15,222

We perform our annual impairment analysis of goodwill as of December 31, or when there is an indication an impairment may have occurred. Under generally accepted accounting principles, we have the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of one or more of our reporting units is greater than its carrying amount. If, after assessing the totality of events or circumstances, we determine it is more likely than not that the fair value of a reporting unit is greater than the carrying amount, there is no need to perform any further testing. However, if we conclude otherwise, then we are required to perform a quantitative impairment test by calculating the fair value of the reporting unit and comparing the fair value with the carrying amount of the reporting unit. If the fair value of the reporting unit is less than the carrying value, an impairment loss is recorded in the amount of that difference. We also have the option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. All goodwill impairment charges are included in “Impairments” in the consolidated statements of operations. See “Note 2. Summary of Significant Accounting Policies” for additional information.

2020 Goodwill Impairment Analysis

As of March 31, 2020, we performed a quantitative impairment analysis for goodwill utilizing a market participant perspective and determined that the fair value exceeded the carrying value of our reporting unit. For our annual assessment, which occurs at December 31 of each year, we elected to perform a qualitative assessment and determined that Repeat Precision, which has goodwill of $15.2 million, did not have a fair value below its net carrying value, and therefore, we did not record any impairment charge for this reporting unit for the year ended 2020.

2019 Goodwill Impairment Charge

During the second quarter of 2019, we performed an impairment analysis for goodwill using the quantitative method. Evidence of an indication of impairment included further deterioration in customer activity levels in North America, which resulted in lower demand for oilfield services driving a decrease in our market share and increased customer and competitor-driven pricing pressures in addition to a decline in the quoted price of our common stock. We determined that the carrying value of one of our reporting units exceeded its fair value and we recorded an impairment charge of $7.9 million for our tracer diagnostic services reporting unit Following the impairment, our tracer diagnostic services reporting unit had no remaining goodwill balance. We had one other reportable unit, Repeat Precision, with a goodwill balance at December 31, 2019. We performed a qualitative assessment and determined that Repeat Precision’s goodwill balance of $15.2 million was not impaired, as the fair value exceeded the net carrying value. Therefore, no impairment was required for this reportable unit for the year ended December 31, 2019.

2018 Goodwill Impairment Charge

On December 31, 2018, we performed our annual impairment analysis for goodwill using the quantitative method on each of our three reporting units. As a result of unfavorable oil and gas industry market conditions in late 2018 that continued to persist into 2019 and the related impact on expected customer activity levels, particularly in Canada, as well as a decline in the quoted price of our common stock, we concluded that there had been an impairment because the carrying values exceeded the estimated fair values. We recorded impairment charges in the fourth quarter of 2018 in two reporting units, totaling $154.0 million. As a result of the impairment loss, we have no remaining goodwill in the fracturing systems and well construction reporting unit.

Identifiable intangibles by major asset class consist of the following (in thousands):



		December 31, 2020
	Estimated	Gross
	Useful	Carrying		Accumulated		Net
	Lives (Years)	Amount		Amortization		Balance
Technology	1 - 20	$	3,958	$	(87)	$	3,871
Customer relationships	10		4,100		(1,606)		2,494
Total amortizable intangible assets		$	8,058	$	(1,693)	$	6,365
Technology - not subject to amortization	Indefinite		48		—		48
Total identifiable intangibles		$	8,106	$	(1,693)	$	6,413



		December 31, 2019
	Estimated	Gross
	Useful	Carrying		Accumulated		Net
	Lives (Years)	Amount		Amortization		Balance
Technology	8 - 18	$	17,721	$	(2,380)	$	15,341
Trademarks	5 - 10		1,600		(373)		1,227
Customer relationships	10 - 21		28,689		(3,928)		24,761
Internally developed software	5		4,904		(985)		3,919
Total identifiable intangibles		$	52,914	$	(7,666)	$	45,248

In December 2020, we recognized a $3.8 million intangible related to the transfer of the U.S. Patent No. 9,810,035 (the “’035 Patent”) from Diamondback Industries, Inc. (“Diamondback”) to Repeat Precision in connection with the litigation settlement. See “Note 10. Commitments and Contingencies” for additional information. Substantially all identifiable intangibles at December 31, 2020 are related to our Repeat Precision asset group.

Identifiable intangibles are tested for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Impairment charges related to identifiable intangibles are included in “Impairments” in the consolidated statements of operations. See “Note 2. Summary of Significant Accounting Policies” for additional information.

2020 Identifiable Intangibles Impairment Charge

On March 31, 2020, we evaluated our finite-lived intangible assets for impairment due to current industry conditions including a reduction in global economic growth expectations, a significantly reduced demand for crude oil and refined products, the significant decline in commodity prices and the corresponding impact on future expectations of demand for our products and services primarily related to the COVID-19 pandemic as well as the resulting decline in the quoted price of our common stock. As a result of the analysis, we determined that the carrying values of certain intangible assets were no longer recoverable, which resulted in an impairment charge of $11.9 million in the asset group that includes fracturing systems and well construction related to technology and internally-developed software and an impairment charge of $28.6 million in our tracer diagnostics asset group related to customer relationships, technology, internally developed software and trademarks, each recorded on March 31, 2020. Following the impairment charges in the first quarter of 2020, we had no remaining identifiable intangible balances in the asset group that includes our fracturing systems and well construction or our tracer diagnostics asset group. There were no impairment charges recorded for our identifiable intangibles for the remainder of the year ended December 31, 2020.

2019 Identifiable Intangibles Impairment Charge

No intangible impairments were recorded in 2019.

2018 Identifiable Intangibles Impairment Charge

On December 31, 2018, as a result of unfavorable oil and gas industry market conditions in late 2018 that continued to persist into early 2019 and the related impact on expected customer activity levels, particularly in Canada, as well as a decline in the quoted price of our common stock, we determined that the carrying values of certain intangible assets were no longer recoverable, which resulted in an impairment charge of $73.5 million in our asset group that includes fracturing systems and well construction, which we recorded in the fourth quarter of 2018.

Amortization

Total amortization expense, which is associated with the selling, general and administrative expenses on the consolidated statements of operations, was $1.5 million, $4.6 million and $13.1 million for the years ended December 31, 2020, 2019 and 2018, respectively.

The total weighted average amortization period is 13 years and estimated future amortization expense is as follows (in thousands):


2021	$	669
2022		669
2023		669
2024		669
2025		669
Thereafter		3,020
Total	$	6,365

Accrued Expenses

12 Months Ended

Dec. 31, 2020

Accrued Expenses [Abstract]

Accrued Expenses

Note 8. Accrued Expenses

Accrued expenses consist of the following as of December 31, 2020 and 2019 (in thousands):



	December 31,		December 31,
	2020		2019
Accrued payroll and bonus	$	999	$	2,558
Property and franchise taxes accrual		505		462
Severance and other termination benefits (Note 11)		730		—
Accrued other miscellaneous liabilities		1,113		431
	$	3,347	$	3,451

Debt

12 Months Ended

Dec. 31, 2020

Debt [Abstract]

Debt

Note 9. Debt

Our long-term debt consists of the following as of December 31, 2020 and 2019 (in thousands):



	December 31,		December 31,
	2020		2019
Senior Secured Credit Facility	$	—	$	10,000
Finance leases		5,789		2,917
Total debt		5,789		12,917
Less: current portion		(1,347)		(1,481)
Long-term debt	$	4,442	$	11,436

The estimated fair value of total debt for the years ended December 31, 2020 and 2019 was $5.6 million and $12.5 million, respectively. The carrying value of the senior secured revolving credit facility and the lines of credit approximated the fair value of debt at December 31, 2019 since this facility had variable interest rates and could be paid at any time. The fair value for the remaining debt was estimated using Level 2 inputs by calculating the sum of the discounted future interest and principal payments at our incremental borrowing rate through the date of maturity.

Below is a description of our credit agreement and other financing arrangements.

Senior Secured Credit Facility

On May 1, 2019, we entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Pioneer Investment, Inc., as borrower (the “U.S. Borrower”), NCS Multistage Inc., as borrower (the “Canadian Borrower”, together with the U.S. Borrower, the “Borrowers”), Pioneer Intermediate, Inc. (together with the Company, the “Parent Guarantors”) and the lenders party thereto, Wells Fargo Bank, National Association as administrative agent in respect of the U.S. Facility (as defined below) and Wells Fargo Bank, National Association, Canadian Branch, as administrative agent in respect of the Canadian Facility (as defined below) (the senior secured revolving credit facilities provided thereunder, the “Senior Secured Credit Facility”). The Credit Agreement amended and restated our prior credit agreement in its entirety.

On August 6, 2020, we entered into Amendment No. 1 (the “Amendment”) to the Credit Agreement (as amended by the Amendment, the “Amended Credit Agreement”) with Pioneer Investment, Inc., as borrower, NCS Multistage Inc., as borrower, Pioneer Intermediate, Inc., certain subsidiaries of the Borrowers, the lenders party thereto, Wells Fargo Bank, National Association as administrative agent in respect of the U.S. Facility and Wells Fargo Bank, National Association, Canadian Branch, as administrative agent in respect of the Canadian Facility (the U.S. Facility and the Canadian Facility, collectively, the “Facilities”).

The Amendment (i) reduced the U.S. Commitments (as defined in the Amended Credit Agreement) from $50.0 million to $25.0 million, of which up to $2.5 million may be made available for letters of credit and up to $2.5 million may be made available for swingline loans and (ii) reduced the Canadian Commitments (as defined in the Amended Credit Agreement) from $25.0 million to $0. The Canadian Borrower may make borrowings under the U.S. Facility, subject to a $15.0 million sublimit. The Amendment also limits total outstanding credit exposure of the lenders under the Facilities to a borrowing base calculated based on eligible receivables, provided that it does not include receivables at Repeat Precision. Our borrowing base under the Senior Secured Credit Facility as of December 31, 2020 was $11.0 million. The maturity date of the Amended Credit Agreement remains May 1, 2023. As of December 31, 2020, we had no outstanding indebtedness under the Senior Secured Credit Facility. As of December 31, 2019, we had $10.0 million in outstanding indebtedness under the Senior Secured Credit Facility.

Borrowings under the Senior Secured Credit Facility may be made in USD for Adjusted Base Rate Advances, and in USD, Canadian dollars or Euros for Eurocurrency Rate Advances (each as defined in the Amended Credit Agreement). Such advances bear interest at the Adjusted Base Rate or at the Eurocurrency Rate (each as defined in the Amended Credit Agreement) plus an applicable interest margin between 2.75% and 3.75%, depending on our leverage ratio. The applicable interest rate at December 31, 2020 was 4.375%. We incurred interest expense related to the Senior Secured Credit Facility, including commitment fees, of $0.6 million and $0.7 million for the years ended December 31, 2020 and 2019, respectively.

Pursuant to amended guaranty and security documents entered into concurrently with the Amendment, the obligations of the Borrowers under the Senior Secured Credit Facility are guaranteed by the Parent Guarantors, as well as each of the other existing and future direct and indirect restricted subsidiaries of NCS organized under the laws of the United States and Canada (subject to certain exceptions), and are secured by substantially all of the assets of the Parent Guarantors, the Borrowers and such other subsidiary guarantors, in each case, subject to certain exceptions and permitted liens.

Prior to giving effect to the Amendment, the Credit Agreement contained financial covenants that required (i) commencing with the fiscal quarter ending June 30, 2019, compliance with a maximum leverage ratio test set at 2.50 to 1.00 as of the last day of each fiscal quarter, (ii) commencing with the fiscal quarter ending June 30, 2019, compliance with an interest coverage ratio test set at not more than 2.75 to 1.00 as of the last day of each fiscal quarter, (iii) if the leverage ratio as of the end of any fiscal quarter is greater than 2.00 to 1.00 and the amount outstanding under the Canadian Facility at any time during such fiscal quarter was greater than $0, compliance as of the end of such fiscal quarter with a Canadian asset coverage ratio test of at least 1.00 to 1.00 and (iv) if the leverage ratio as of the end of any fiscal quarter is greater than 2.00 to 1.00 and the amount outstanding under the Senior Secured Credit Facility at any time during such fiscal quarter was greater than $0, compliance as of the end of such fiscal quarter with a U.S. asset coverage ratio test of at least 1.00 to 1.00. Pursuant to the Amendment, we are no longer required to comply with the foregoing financial covenants.

Pursuant to the Amendment, the Amended Credit Agreement now requires us to (i) maintain liquidity (defined as availability under the Senior Secured Credit Facility plus certain cash deposits) of at least $7.5 million as of the date of each borrowing base certificate due to be delivered either monthly (if availability is greater than or equal to than 12%) or weekly (if availability is less than 12%) thereunder, (ii) maintain, for quarters during which availability is less than 20% of the borrowing base, a fixed charge coverage ratio of at least 1.0 to 1.0 and (iii) on the last business day of each week, prepay advances to the extent that available cash exceeds $12.0 million. As of December 31, 2020, we were in compliance with these financial covenants. The Amendment also narrowed or eliminated several exceptions to prohibitions on the creation of liens, the incurrence of indebtedness, the making of investments and restricted payments and other negative covenants, rendering these covenants generally more restrictive. The Amendment reduced the dollar thresholds above which certain cross-defaults and adverse employee benefit plan events constitute events of default. The Amendment added a new event of default if the indebtedness of Repeat Precision exceeds $10.0 million.

The Amended Credit Agreement includes customary events of default for facilities of this type (with customary materiality thresholds and grace periods, as applicable). If an event of default occurs, the lenders party to the Amended Credit Agreement may elect (after the expiration of any applicable notice or grace periods) to declare all outstanding borrowings under such facility, together with accrued and unpaid interest and other amounts payable thereunder, to be immediately due and payable. The lenders party to the Amended Credit Agreement also have the right upon an event of default thereunder to terminate any commitments they have to provide further borrowings and to proceed against the collateral securing the Senior Secured Credit Facility.

We believe that our cash on hand, cash flows from operations and potential borrowings under our Senior Secured Credit Facility will be sufficient to fund our capital expenditures and liquidity requirements for the next twelve months. However, if the depressed market conditions, including reduced demand for oil, lower customer spending and the resulting low level of demand for our products and services continue, it will have a material negative impact on our financial performance. We can make no assurances that the current actions taken by us will provide us with enough liquidity in the future if the current economic environment worsens.

Direct costs of $0.9 million were incurred in 2019 in connection with the Senior Secured Credit Facility in addition to $0.3 million of unamortized deferred costs related to the modification of the prior senior secured credit facility. The costs were capitalized as an asset as they represent the benefit of being able to access capital over the contractual term and were being amortized over the term of the Senior Secured Credit Facility using the straight-line method. The Amendment reduced the overall potential capacity under the Amended Credit Agreement from $75.0 million to $25.0 million. Therefore, we expensed $0.6 million of deferred loan costs during the third quarter of 2020, which was commensurate with the reduction in potential capacity. We recorded new deferred loan costs associated with the Amendment totaling $0.6 million, which have been capitalized and will be amortized over the remaining term of the facility. Amortization expense of the deferred financing charges of $0.3 million and $0.2 million was included in interest expense, net for the years ended December 31, 2020 and 2019.

Promissory Note

On February 27, 2017, Repeat Precision entered into a promissory note with Security State Bank & Trust, Fredericksburg, for an aggregate borrowing capacity of $3.8 million. The note bears interest at a variable interest rate based on prime plus 1.00%. The promissory note is collateralized by certain equipment, inventory and receivables. The promissory note was renewed on February 16, 2018 for an aggregate borrowing capacity of $4.3 million and was renewed again on February 12, 2021. The note is scheduled to mature on February 12, 2022. Total borrowings are limited by a borrowing base calculated based on a portion of eligible receivables, inventory and equipment. No other terms were changed. For the years ended December 31, 2020 and 2019, we had no outstanding indebtedness under the promissory note.

On April 30, 2020, Repeat Precision entered into a promissory note with Security State Bank & Trust, Fredericksburg, for an aggregate borrowing capacity of $5.0 million. The note bears interest at a variable interest rate based on prime plus 1.00%. The promissory note is collateralized by certain equipment and inventory. The note is scheduled to mature on April 30, 2021. Total borrowings are limited by a borrowing base calculated based on a portion of eligible receivables, inventory and equipment. As of December 31, 2020, we had no outstanding indebtedness under the promissory note.

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2020
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 10. Commitments and Contingencies Litigation In the ordinary course of our business, from time to time, we have various claims, lawsuits and administrative proceedings that are pending or threatened with respect to commercial, intellectual property and employee matters. On July 24, 2018, we filed a patent infringement lawsuit against Kobold Corporation, Kobold Completions Inc. and 2039974 Alberta Ltd. (“Kobold”) in the Federal Court of Canada, alleging that Kobold’s fracturing tools and methods infringe on several of our Canadian patents. We previously filed a breach of contract lawsuit on March 16, 2018, against Kobold Corporation in the Court of Queen’s Bench of Alberta, alleging breach of a prior settlement agreement. Both of these lawsuits seek unspecified monetary damages and injunctive relief. On July 12, 2019, Kobold filed a counterclaim seeking unspecified damages alleging that our fracturing tools and methods infringe on their patent and that we made false and misleading statements about Kobold. On April 3, 2020, the United States District Court for the Western District of Texas, Waco Division (“Waco District Court”) issued a final judgment in connection with the litigation with Diamondback awarding Repeat Precision approximately $39.9 million (the “Award”) plus attorneys’ fees in connection with its breach of exclusive license, patent infringement of the ‘035 Patent and tortious interference claims. In addition, in April 2020, we received $1.1 million of proceeds from our directors and officers liability insurance related to the reimbursement of legal expenses that we incurred to defend a director and officer in the Diamondback litigation. On April 21, 2020, Diamondback filed for Chapter 11 bankruptcy protection which stayed collection efforts. In October 2020, we entered into an agreement to settle the Award entered into by the Waco District Court, which was effectuated through a Chapter 11 plan of reorganization that was filed by Diamondback that became effective on December 10, 2020. On the effective date, in connection with Repeat Precision releasing Diamondback and Derrek Drury (“Drury”) from the monetary damages in the Award and certain other claims, Repeat Precision received: (i) an upfront cash payment of approximately $15.5 million, (ii) the transfer of the ‘035 Patent from Diamondback to Repeat Precision, (iii) payments for future sales of certain setting tool sold by Diamondback or its successor as restitution, until $5 million has been paid in total, and (iv) a note from Drury payable in two years, which was paid off prior to year-end 2020, in the principal amount of $5 million. Repeat Precision and another claimant in the Diamondback bankruptcy have also agreed to provide mutual releases of all claims in exchange for consideration to be received by Repeat Precision. As of December 31, 2020, we recorded a total of $25.7 million as a gain on patent infringement settlement in our consolidated financial statements related to this gain contingency, which also includes the $1.1 million of proceeds from our directors and officers liability insurance mentioned above and is net of related legal fees incurred in 2020 of $2.7 million. On April 8, 2020, we filed a lawsuit alleging infringement of U.S. Patent No. 10,465,445 (the “‘445 Patent”) against Nine Energy Service, Inc. (“Nine”) in the Waco District Court. On July 9, 2020, we filed a lawsuit against TCO AS (“TCO”) also alleging infringement of the ‘445 Patent. The claim construction hearing for the Nine lawsuit was heard in the Waco District Court on January 14, 2021. On February 18, 2021, the Patent Trial and Appeal Board decided to not institute a trial with regards to TCO’s request for a ‘445 Patent post-grant review. The litigation against Nine and TCO is currently scheduled for trial beginning October 18, 2021 and March 6, 2022, respectively. On February 12, 2021, Nine filed a lawsuit against us alleging infringement of their U.S. Patent No. 10,871,053 in the Waco District Court. All of these lawsuits seek unspecified monetary damages and injunctive relief. In accordance with GAAP, we accrue for contingencies where the occurrence of a material loss is probable and can be reasonably estimated, based on our estimate of the expected liability. If we have any outstanding legal accruals, we may increase or decrease these in the future, on a matter-by-matter basis, to account for developments. Our assessment of the likely outcome of litigation matters is based on our judgment of a number of factors, including experience with similar matters, past history, precedents, relevant financial information and other evidence and facts specific to the matter. While the outcome of any legal proceeding cannot be predicted with any certainty, based on a consideration of relevant facts and circumstances, our management currently does not expect that the results of these legal proceedings would have a material adverse effect on our financial position, results of operations or cash flows. Technical Services and Assistance Agreement We entered into a technical services and assistance agreement with Special Oilfield Services Co. LLC (“SOS”), which is effective until the expiration of a specified contract between SOS and a third party or the expiration of other contracts entered into subsequent to the specified contract. Pursuant to the agreement, NCS will provide chemical tracers and radioactive isotopes at a stated contract price with revenue recognized on the delivery of these materials when performance obligations are met. In addition, we provide technical support, training, literature and further technical back up to SOS pursuant to a collaborative arrangement. In consideration of these technical services, SOS shares the net profit or loss, excluding certain non-cash items, arising out of the specified contractual arrangement equally with NCS at the end of each year. The net profit or loss is calculated based on total revenues less expenses per year with SOS deducting a 10% withholding tax on any profit payable to NCS. All assets of the contractual arrangement are owned by SOS. The amount of profit sharing was unable to be estimated during the first year of the contract until the end of the performance period. The amount of net profit or loss is still subject to change after year end after the annual profit sharing audit. However, since the performance period has ended as of December 31, 2020 and the amount of the profit sharing is probable and reasonably estimable, we have recorded a receivable related to this profit sharing provision totaling $1.1 million, net of withholding tax of $0.1 million. A portion of the profit sharing income is allocated to tracer diagnostics services based upon the ratio of the standalone fair market value of the tracer materials and profit sharing elements of the contractual arrangement. For the year ended December 31, 2020, we have recorded tracer diagnostics services revenue of $1.6 million and other income, net totaling $0.9 million related to this agreement in the consolidated statements of operations. We expect to collect the profit sharing receivable in or before April 2021.

Severance and Other Termination Benefits

12 Months Ended

Dec. 31, 2020

Severance and Other Termination Benefits [Abstract]

Severance and Other Termination Benefits

Note 11. Severance and Other Termination Benefits

On March 31, and April 1, 2020, we implemented, effective as of such date, a workforce reduction resulting in the termination of over 80 employees, temporary furloughs for certain employees and lower compensation levels for executives and employees not participating in furloughs and on May 4, 2020 and in July 2020, we implemented, effective as of such date, additional workforce reductions resulting in the termination of approximately 50 employees per each reduction in response to the decrease in crude oil pricing, customer capital spending plans and activity as a result of the decline in market conditions primarily related to the COVID-19 pandemic and reduced demand for oil. In connection with these reductions in workforce and executive departures, we incurred cash severance costs, which are reflected in the consolidated statements of operations under general and administrative expenses, of $5.7 million for the year ended December 31, 2020.

Below is a reconciliation of the beginning and ending liability balance (in thousands):


Beginning balance, December 31, 2019	$	—
Additions for costs expensed		5,661
Severance payments		(4,969)
Currency translation adjustment		38
Ending balance, December 31, 2020	$	730

We expect to finish paying off this severance and other termination benefits liability by May 2021.

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Dec. 31, 2020
Stockholders' Equity [Abstract]
Stockholders' Equity	Note 12. Stockholders’ Equity Reverse Stock Split In connection with our efforts to regain compliance with the minimum price per share criteria for continued listing set forth in Nasdaq Listing Rule 5450(a)(1), we effected a reverse stock split of our issued and outstanding common stock on December 1, 2020. On October 27, 2020, funds affiliated with Advent International Corporation, who beneficially held an aggregate 29,568,536 shares on a pre-split basis as of the record date of the reverse stock split, or approximately 62.6% of our shares of common stock, executed and delivered to the Board of Directors a written consent approving a proposal to effect a reverse stock split of our issued and outstanding common stock, with a ratio of 1-for-20, and to reduce the number of authorized shares of our common stock by the same ratio as the reverse stock split. Our Board of Directors also approved the above reverse stock split and authorized share reduction on October 27, 2020. Our common stock began trading on Nasdaq on a split-adjusted basis when the market opened on December 1, 2020. The reverse stock split resulted in a reduction of the number of publicly held shares of NCS below the minimum 750,000 publicly held shares requirement set forth in Nasdaq Listing Rule 5450(b)(1)(B) and thus NCS applied to transfer its securities to the Nasdaq Capital Market on December 17, 2020, which was approved on December 22, 2020, with the transfer occurring at the opening of business on December 24, 2020. This transfer to the Nasdaq Capital Market is not expected to affect the trading of the common stock. The Capital Market is a continuous trading market that operates in substantially the same manner as the Global Select Market. The par value of the common and preferred stock was not adjusted as a result of the stock split. All other issued and outstanding common shares and per share amounts included in the consolidated financial statements herewith have been adjusted to reflect this reverse stock split for all periods presented. Authorized and Outstanding Shares On December 1, 2020, our certificate of incorporation was amended and the number of shares of common stock authorized to be issued was decreased from 225,000,000 to 11,250,000. The number of our authorized shares of preferred stock remained 10,000,000 shares. As of December 31, 2020 and 2019, 2,359,918 and 2,340,656 shares of common stock were outstanding, respectively. Voting The holders of common stock are entitled to one vote for each share of common stock held. Dividends The holders of common stock are entitled to receive dividends as declared from time-to-time by our Board, to the extent permitted under the Senior Secured Credit Facility. No dividends were declared during the periods ended December 31, 2020 or December 31, 2019.

Share-Based Compensation

12 Months Ended

Dec. 31, 2020

Share-Based Compensation [Abstract]

Share-Based Compensation

Note 13. Share-Based Compensation

Equity Incentive Plans

We maintain two equity incentive plans for the benefit of our employees, directors and other service providers: our 2012 Equity Incentive Plan (the “2012 Plan”) and our 2017 Equity Incentive Plan (the “2017 Plan”). The following is a summary of certain features of the 2012 Plan and the 2017 Plan.

2012 Plan

The 2012 Plan provided awards to our employees, directors and consultants. We no longer grant awards under the 2012 Plan. The 2012 Plan is administered by the Compensation, Nominating and Governance Committee of our Board. The 2012 Plan has a total of 123,175 shares authorized for issuance. Awards granted under the 2012 Plan will remain outstanding until the earlier of exercise, forfeiture, cancellation or expiration. As of December 31, 2020, there remain 97,452 options outstanding, of which 97,327 options are exercisable, which were granted pursuant to the 2012 Plan.

2017 Plan

The 2017 Plan replaced the 2012 Plan and provides for awards of stock options, stock appreciation rights, restricted stock awards, RSUs, stock awards and performance awards. Awards under the 2017 Plan may be granted to any employee, non-employee director, consultant or other personal service provider to us or any of our subsidiaries. The 2017 Plan is administered by a plan administrator, which is the Compensation, Nominating and Governance Committee or such other committee of the Board or the Board as a whole, in each case as determined by the Board. The 2017 Plan was established with the authorization for grants of up to 226,626 shares of authorized but unissued shares of common stock. During 2020, NCS increased the number of authorized shares by 325,000 shares of common stock, which increased the maximum aggregate number of shares available to be issued under the 2017 Plan to 551,626 shares. As of December 31, 2020, the total number of shares available for future issuance under the 2017 Plan is 383,848 shares.

Stock Options

Stock options granted under the 2012 Plan and the 2017 Plan generally vest annually in equal increments over three or five years and have a 10-year term. When we were a private company, we issued certain stock options that were to vest only in connection with a change of control (the “Liquidity Options”). When we completed our initial public offering during the second quarter of 2017, the Liquidity Options were amended for 22 employees to provide that such awards will vest in three equal installments, subject to certain requirements including, as applicable, the recipient’s continued employment on the vesting date.

Determining fair market value

We estimated the fair value of each option grant using the Black-Scholes option-pricing model. The Black-Scholes option pricing model requires estimates of key assumptions based on both historical information and management judgment regarding market factors and trends. Determining the appropriate fair value model and calculating the fair value of options requires the input of highly subjective assumptions, including the expected volatility of the price of our stock, the risk-free rate, the expected term of the options and the expected dividend yield of our common stock. These estimates involve inherent uncertainties and the application of management’s judgment. If factors change and different assumptions are used, our share-based compensation expense could be materially different in the future.

Expected volatility—As we were a private company prior to the second quarter of 2017, we estimated our expected volatility by using the historical volatilities of our peer group of public companies for a period equal to the expected life of the option by taking the median of the annualized weekly ten-year standard deviation of their stock prices.

Risk-free interest rate—The risk-free interest rates for options granted are based on the constant maturity Treasury bond rates whose term is consistent with the expected life of an option from the date of grant.

Expected term—As we did not have sufficient historical experience for determining the expected term of the stock option awards granted, we based our expected term for awards issued to employees on the “simplified” method under the provisions of ASC Topic 718-10, Compensation-Stock Compensation. The expected term is based on the midpoint between the vesting date and contractual term of an option. The expected term represents the period that our stock-based awards are expected to be outstanding.

Expected dividend yield—We do not anticipate paying cash dividends on our shares of common stock; therefore, the expected dividend yield is assumed to be zero.

The following table summarizes stock option activity during the year ended December 31, 2020:



2012 Equity Plan and 2017 Equity Plan	Service Based Options	Liquidity Options	Total Options	Service Based Weighted Average Exercise Price		Liquidity Based Weighted Average Exercise Price		Service Based Weighted Average Remaining Contractual Life (Years)	Liquidity Weighted Average Remaining Contractual Life (Years)
Outstanding at December 31, 2019	42,752	63,411	106,163	$	122.39	$	123.14	3.22	3.16
Granted during the year	—	—	—		—		—
Exercised during the year	(675)	—	(675)		0.20		—
Forfeited during the year	(150)	(1,109)	(1,259)		191.20		149.99
Expired during the year	(2,425)	(3,720)	(6,145)		122.67		147.69
Outstanding at December 31, 2020	39,502	58,582	98,084	$	124.20	$	121.07	2.11	2.07
Unvested as of December 31, 2020	125	—	125		193.40		—
Exercisable as of December 31, 2020	39,377	58,582	97,959	$	123.98	$	121.07	2.11	2.07

Aggregate intrinsic value represents the difference between our estimated fair value of common stock and the exercise price of outstanding in the money options. As of December 31, 2020, our outstanding, unvested and exercisable aggregate intrinsic values had no value. The total intrinsic value of options exercised during the years ended December 31, 2020 and 2018 for all equity incentive plans was $6 thousand and $9.8 million, respectively. No options were exercised during the year ended December 31, 2019. The income tax benefit realized from stock options exercised was $1 thousand and $0.5 million for the years ended December 31, 2020 and 2018, respectively.

As of December 31, 2020, there was $6 thousand of total unrecognized compensation cost related to options, which we expect to recognize over a weighted average period of less than one year.

Restricted Stock Units

During the second quarter of 2017, we began granting RSUs. We account for RSUs granted to employees at fair value on the date of grant, which we measure as the closing price of our stock on the date of grant, and recognize the compensation expense in the financial statements over the requisite service period. RSUs generally vest over a period of three equal annual installments beginning on the anniversary of the date of grant other than those issued to members of our Board. Prior to 2019, the RSUs for the members of our Board generally vested on the one year anniversary of the grant date but will settle for shares of common stock on a one-for-one basis within thirty days following the earliest of (i) one year following the termination of the person’s service for any reason other than cause, (ii) a change of control or (iii) the fifth anniversary of the grant date. Beginning in 2019, the RSUs for the members of our Board either settle within thirty days of vesting or, if the director has elected to defer the RSUs, within thirty days following the earlier of the termination of the director’s service for any reason or a change of control.

The following table summarizes RSU activity during the year ended December 31, 2020:


	Number of Awards	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2019	66,819	$	158.61
Granted	25,047		22.11
Vested (including 4,371 shares that have not been released)	(30,401)		166.84
Forfeited	(12,434)		121.81
Non-vested at December 31, 2020	49,031	$	93.11

The total value of shares vested and released was $0.5 million, $1.0 million and $0.6 million during the years ended December 31, 2020, 2019 and 2018. For 2020, 2019 and 2018, the income tax benefit recognized for RSUs was $0.1 million, $0.2 million and $0.1 million, respectively. As of December 31, 2020, there was $1.7 million of total unrecognized compensation cost related to RSUs, which we expect to recognize over a weighted average period of less than one year.

Equivalent Stock Unit Awards

During 2019, we began granting ESUs. When the ESUs are originally granted to employees, they are valued at fair value, which we measure as the closing price of our common stock on the date of grant. As the ESUs will be settled in cash, we record a liability which is remeasured each reporting period at fair value based upon the closing price of our common stock until the awards are settled. The ESUs will vest and settle ratably in three equal annual installments beginning on the anniversary of the date of grant. The cash settled for any ESU will not exceed the maximum payout established by our Compensation, Nominating and Governance Committee, which is generally two times the fair market value of our common stock as of a day near the grant date.

The following table summarizes ESU activity during the year ended December 31, 2020:


	Number of Awards	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2019	28,790	$	110.21
Granted	150,036		21.71
Vested	(9,609)		110.21
Forfeited	(34,425)		36.58
Non-vested at December 31, 2020	134,792	$	30.50

During the year ended December 31, 2020, we paid $0.2 million upon settlement of the ESUs. As of December 31, 2020, the total liability for ESUs was $0.9 million.

Performance Stock Unit Awards

We have granted PSUs to certain executives on an annual basis since 2018. PSUs provide for the recipients to receive a grant of shares of common stock based upon the achievement of certain performance goals over a specified period established by the Compensation, Nominating, and Corporate Governance Committee. The number of PSUs ultimately issued is dependent upon our total shareholder return relative to our performance peer group (“relative TSR”) over a three-year performance period. Each PSU will settle for between zero and two shares of our common stock. The threshold performance level (25th percentile relative TSR) starts to earn PSUs, the mid-point performance level (50th percentile relative TSR) earns 65% of the target PSUs and the maximum performance level (90th percentile relative TSR) or greater earns 200% of the target PSUs.

The grant date fair value of the PSUs in 2020, 2019 and 2018 were measured using a Monte Carlo simulation with the following assumptions and the resulting weighted-average grant date fair value per share:


	2020			2019			2018
Grant date		February 28, 2020			February 28, 2019			March 1, 2018
Performance period		January 1, 2020 to December 31, 2022			January 1, 2019 to December 31, 2021			January 1, 2018 to December 31, 2020
Volatility		70.7	%		63.2	%		54.3	%
Risk-free interest rate		0.9	%		2.5	%		2.3	%
Expected dividends		—	%		—	%		—	%
Grant date price	$	21.80		$	110.20		$	290.60
Weighted-average fair value per share	$	26.20		$	130.00		$	347.40

The following table summarizes PSU activity during the year ended December 31, 2020:


	Number of Awards	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2019	26,684	$	193.80
Granted	51,806		26.20
Vested	—		—
Forfeited	(7,821)		347.61
Non-vested at December 31, 2020	70,669	$	53.91

As of December 31, 2020, there was $1.7 million of total unrecognized compensation cost related to PSUs, which we expect to recognize over a weighted average period of two years.

Employee Stock Purchase Plan

On August 3, 2017, our Board adopted our ESPP. When adopted, there were an aggregate of 100,000 shares of our common stock reserved for issuance and sale pursuant to the ESPP. The ESPP allows eligible employees to contribute, subject to any other plan limitations including a maximum share purchase cap of 52 shares per offering period, up to 18% of their base salary, up to a maximum of $12.5 thousand per offering period, toward the purchase of our common stock at a discounted price. The purchase price of the shares on each purchase date is equal to 85% of the lower of the fair market value of our common stock on the first and last trading days of each offering period. The U.S. ESPP is designed to be qualified under Section 423 of the Internal Revenue Code. As of December 31, 2020, there were 86,416 shares available for issuance in the ESPP. In January 2019, we issued 7,824 shares of our common stock to our employees in connection with the settlement of the purchase of shares for the October 16, 2017 to December 31, 2018 offering period. In July 2019, we issued 5,760 shares of our common stock to our employees in connection with the settlement of the purchase of shares for the January 1, 2019 to June 30, 2019 offering period. Both of these issuances increased our common stock outstanding. The ESPP was temporarily suspended for future offering periods beginning on July 1, 2019.

The fair values of the ESPP for the January 1, 2019 to June 30, 2019 and October 16, 2017 to December 31, 2018 offering periods were estimated using the Black-Scholes model with the following assumptions and resulting weighted-average fair value per share:


	January 1, 2019 to June 30, 2019			October 16, 2017 to December 31, 2018
Expected volatility		82.8	%		38.8	%
Average risk-free interest rate		2.5	%		1.4	%
Expected dividends		—	%		—	%
Weighted-average fair value per share	$	40.40		$	143.20

Total Share Based Compensation Expense

The following table summarizes share-based compensation expense recognized in SG&A expense in our consolidated statements of operations and our related tax benefit for the years ended December 31, 2020, 2019 and 2018, respectively (in thousands):


	Year Ended December 31,
	2020		2019		2018
Stock options	$	1,459	$	5,263	$	5,865
Restricted stock units		3,921		5,032		3,672
Equivalent stock units		759		338		-
Performance stock unit awards		2,343		1,682		800
ESPP		-		227		593
Total share-based compensation expense	$	8,482	$	12,542	$	10,930
Related income tax benefit	$	92	$	157	$	1,698

Employee Benefit Plan	12 Months Ended
Employee Benefit Plan	Dec. 31, 2020
Employee Benefit Plan [Abstract]
Employee Benefit Plan	Note 14. Employee Benefit Plan Our U.S. employees are eligible to participate in a 401(k) plan sponsored by us. All eligible employees may contribute a percentage of their compensation subject to a maximum imposed by the Internal Revenue Code. Under the terms of the 401(k) plan, we match 100% of the first 3% of eligible compensation an employee contributes. Additionally, for contributing in excess of the first 3% of eligible compensation we provide a 50% match on any employee contribution up to 4% of eligible compensation. Similarly, our Canadian employees are eligible to participate in the Group Registered Retirement Savings Program. All eligible employees may make tax deferred contributions to the plan. Contributions made on behalf of Canadian employees by NCS are taxable income to the employee and may not exceed the Canadian Revenue Agency’s deduction limit for the given year. The employer contributions for the 401(k) plan and the Group Registered Retirement Savings Program were suspended beginning on June 1, 2020. Our contributions to these benefit plans were $0.6 million, $1.5 million and $1.3 million for the years ended December 31, 2020, 2019 and 2018, respectively.

Leases

12 Months Ended

Dec. 31, 2020

Leases [Abstract]

Leases

Note 15. Leases

We determine if a contract contains a lease at the inception of an arrangement. If so, ROU assets representing the right to use an underlying asset for the lease term and lease liabilities representing an obligation to make lease payments arising from the lease are included on the consolidated balance sheet.

We have operating and finance leases for facilities, vehicles, and equipment. Some leases include one or more options to renew, with renewal terms that can extend the lease term from five to ten years with exercise of lease renewal options being at the sole discretion of NCS as lessee. Certain leases also include options to purchase the leased property. Some leases may include an option to terminate the contract with notice. ROU assets and lease liabilities with a term of longer than 12 months are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, our interest rate under the senior secured revolving credit facility, adjusted on an annual basis, is used as an incremental borrowing rate applied to the present value calculation at the lease commencement date unless the implicit rate is readily determinable. Lease expense for operating leases is recognized on a straight-line basis over the lease term. We adopted ASU No. 2016-02, Leases (Topic 842) effective January 1, 2019. Upon adoption, ROU assets included any lease payments already made and excluded any initial direct costs.

Our lease agreements are from a lessee perspective and do not contain (i) any leases with variable lease payments (e.g., payments that depend on a percentage of sales of a lessee or payments that increase based upon an index such as a consumer price index), (ii) residual value guarantees probable of being paid, except leased fleet vehicles, or (iii) material restrictive covenants. Lease agreements with lease and non-lease components are generally accounted for separately when practical. For leases where the lease and non-lease component are comingled and the non-lease component is determined to be insignificant when compared to the lease component, the lease and non-lease components are treated as a single lease component for all asset classes.

In February 2020, we commenced an operating lease for our corporate headquarters in Houston, Texas and recorded a long-term asset totaling $2.4 million and a corresponding lease liability. The lease had an initial seven and a half year term with two renewal periods available for an additional five years each.

In May 2020, we commenced a finance lease for land and a building in Odessa, Texas and recorded a long-term asset totaling $4.0 million and a corresponding finance lease liability. The lease had an initial ten-year term with two renewal periods available for an additional five years each.

We also maintain a vehicle leasing arrangement with a fleet management company in order to lease light vehicles and trucks that meet the criteria to record as finance leases. Due to unfavorable market conditions during 2020 associated primarily with the COVID-19 pandemic, we returned many of these vehicles to the fleet management company for sale. During the year ended December 31, 2020, we retired lease vehicles with a historical cost of $3.1 million and accumulated depreciation of $1.9 million, or a net book value of $1.2 million, and an outstanding lease obligation totaling $0.8 million. The fleet management company sold the vehicles and we received proceeds of $1.0 million as of December 31, 2020. The surrender of the assets for sale and the retirement of the related lease obligations of $0.8 million has been included as a non-cash investing and financing activity in the accompanying consolidated statements of cash flows for the year ended December 31, 2020.

As of December 31, 2020, we do not have any lessor leases. Repeat Precision entered into an additional significant lease in Odessa, Texas that had not commenced as of December 31, 2020 in the amount of $2.6 million.

Supplemental balance sheet information related to leases are as follows (in thousands):


			December 31,		December 31,
Leases	Consolidated Balance Sheet Classification		2020		2019
Assets
Operating	Operating lease assets	$	5,170	$	5,071
Finance (1)	Property and equipment, net		5,851		3,379
Total leased right-of-use assets		$	11,021	$	8,450

Liabilities
Current
Operating	Operating lease liabilities	$	1,826	$	2,052
Finance	Current maturities of long-term debt		1,347		1,481

Noncurrent
Operating	Operating lease liabilities, long-term		3,989		3,487
Finance	Long-term debt, less current maturities		4,442		1,436
Total lease liabilities		$	11,604	$	8,456

_______________

(1)

Finance lease right-of-use assets are recorded net of accumulated amortization of $2.2 million and $2.4 million as of December 31, 2020 and 2019, respectively.

The components of lease expense are as follows (in thousands):


		Year Ended December 31,
Lease Cost	Consolidated Statements of Operations Classification	2020		2019
Operating lease cost	Cost of sales; Selling, general and administrative expenses	$	2,193	$	2,891
Finance lease cost
Amortization of right-of-use assets	Depreciation		1,503		1,409
Interest on lease liabilities	Interest expense, net		300		257
Short-term lease cost	Cost of sales; Selling, general and administrative expenses		1,280		898
Total lease cost		$	5,276	$	5,455

Total lease expense charged to consolidated statements of operations for operating leases was $3.5 million, $3.8 million and $3.4 million for the years ended December 31, 2020, 2019, and 2018, respectively.

Maturities of lease liabilities are as follows (in thousands):


Year Ending December 31,	Operating Leases		Finance Leases
2021	$	2,074	$	1,597
2022		1,335		1,274
2023		837		742
2024		744		493
2025		613		492
Thereafter		930		2,182
Total lease payments	$	6,533	$	6,780
Less: interest		718		991
Present value of lease liabilities	$	5,815	$	5,789

Lease term and discount rate consist of the following:


	December 31,			December 31,
Lease Term and Discount Rate	2020			2019
Weighted-average remaining lease term (years):
Operating leases		4.1			2.9
Finance leases		7.2			1.6
Weighted-average discount rate:
Operating leases		5.4	%		5.9	%
Finance leases		4.9	%		5.5	%

Supplemental cash flow and other information related to leases are as follows (in thousands):


	Year Ended		Year Ended
	December 31,		December 31,
Other Information	2020		2019
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	2,324	$	3,278
Operating cash flows from finance leases		300		257
Financing cash flows from finance leases		1,634		1,705

Income Taxes

12 Months Ended

Dec. 31, 2020

Income Taxes [Abstract]

Income Taxes

Note 16. Income Taxes

The provision (benefit) from income taxes consists of the following for the years ended December 31, 2020, 2019 and 2018 (in thousands):


	Year Ended December 31,
	2020		2019		2018
Current tax expense (benefit)
U.S. Federal	$	(413)	$	(382)	$	1,241
State		(183)		221		240
Foreign		(3,985)		1,913		4,307
Total current		(4,581)		1,752		5,788
Deferred tax expense (benefit)
U.S. Federal	$	—	$	8,746	$	(9,525)
State		—		580		(599)
Foreign		(3,202)		(326)		(18,716)
Total deferred		(3,202)		9,000		(28,840)
Total income taxes	$	(7,783)	$	10,752	$	(23,052)

The following is the domestic and foreign components of our (loss) income before income taxes for the years ended December 31, 2020, 2019 and 2018 (in thousands):


	Year Ended December 31,
	2020		2019		2018
U.S. Federal	$	(25,086)	$	(13,762)	$	(52,523)
Foreign		(21,803)		1,696		(155,760)
Loss before income tax	$	(46,889)	$	(12,066)	$	(208,283)

The following is a summary of the items that caused recorded income taxes to differ from income taxes computed using the statutory federal income tax rate for the years ended December 31, 2020, 2019 and 2018:


	Year Ended December 31,
	2020		2019		2018
Income tax at federal statutory rate	21.0	%	21.0	%	21.0	%
Increase (decrease) in income taxes resulting from
Impairment expense	-	%	(2.6)	%	(15.7)	%
Foreign taxes on U.S. income	2.6	%	(12.1)	%	-	%
Non-controlling interest gain/losses	6.7	%	15.7	%	0.5	%
U.S. tax on foreign earnings	(1.7)	%	(5.7)	%	1.5	%
Nondeductible expenses	1.2	%	(3.7)	%	(0.2)	%
Deductible foreign taxes	(0.1)	%	2.7	%	-	%
Non U.S. income taxed at different rates	3.2	%	(1.2)	%	4.5	%
Research and other tax credits	0.9	%	6.4	%	0.4	%
Effect of rate change on deferred tax	(0.7)	%	1.9	%	-	%
Stock-based compensation	(2.2)	%	(7.7)	%	(0.2)	%
State taxes	1.1	%	4.1	%	0.2	%
Change in valuation allowance	(16.9)	%	(108.6)	%	(0.5)	%
Other	1.5	%	0.7	%	(0.4)	%
Income tax	16.6	%	(89.1)	%	11.1	%

We recorded a tax (benefit) expense of $(7.8) million, $10.8 million and $(23.1) million for the years ended December 31, 2020, 2019 and 2018, respectively. For the years ended December 31, 2020, 2019 and 2018, our effective tax rate was 16.6%, (89.1)% and 11.1%, respectively. Included in the tax benefit for the year ended December 31, 2020 were several U.S. tax (benefit) expense adjustments related to the enactment of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) including a tax benefit of $(0.9) million related to a Net Operating Loss (“NOL”) carryback allowed under the CARES Act that was previously unavailable, and a tax expense of $6.5 million for an increase in a valuation allowance on deferred tax assets not expected to be realized. Also included in tax benefit for the year ended December 31, 2020 was a tax expense of $1.4 million for a valuation allowance against our Canadian deferred tax asset based on management’s position that NCS has not met the more likely than not condition of realizing part of the deferred tax asset, as well as a benefit of $(1.5) million related to non-U.S. income taxed at different rates. Included in tax expense for the year ended December 31, 2019 was a tax expense of approximately $13.1 million for a valuation allowance against our U.S. deferred tax asset based on management’s position that we have not met the more likely than not condition of realizing the deferred tax asset as well as the tax effect of a non-deductible goodwill impairment. The income tax benefit and effective tax rate for the year ended December 31, 2018 was significantly impacted by a tax expense of $32.8 million related to impairment charges.

On March 27, 2020, the CARES Act was enacted and signed into law and includes several provisions for corporations including allowing companies to carryback certain NOLs and increasing the amount of NOLs that corporations can use to offset income. Corporate taxpayers may carryback NOLs originating during 2018 through 2020 for up to five years. In addition, the CARES Act removes the 80% taxable income limitation on utilization of those NOLs if carried back to prior tax years or utilized in tax years beginning before 2021.

The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities as of December 31, 2020 and 2019 are as follows (in thousands):


	December 31,
	2020		2019
Deferred tax assets
Accruals not currently deductible	$	6,579	$	6,076
Depreciation and amortization		12,019		5,097
Foreign tax credit carryforward		—		778
Tax loss carryforward		1,284		269
Other		2,735		2,074
		22,617		14,294
Valuation allowance for deferred tax assets		(22,312)		(14,226)
Total deferred tax assets		305		68
Deferred tax liabilities
Depreciation and amortization		—		(3,006)
Foreign currency translation		(78)		(7)
Other		(35)		(5)
Total deferred tax liabilities		(113)		(3,018)
Net deferred tax assets (liabilities)	$	192	$	(2,950)

The above are included in the accompanying consolidated balance sheet as follows (in thousands):


	December 31,
	2020		2019
Deferred income tax assets—noncurrent	$	205	$	6
Deferred income tax liabilities—noncurrent		(13)		(2,956)
	$	192	$	(2,950)

A valuation allowance has been provided for $20.7 million and $14.2 million against U.S. deferred tax assets as of December 31, 2020 and 2019, respectively. Also, for the year ended December 31, 2020, a valuation allowance has been provided for $1.4 million against our Canadian deferred tax assets. We believe we have not met the more likely than not condition of realizing the benefits of these assets based on management’s position regarding the existence of sufficient projected taxable income of the appropriate character.

Segment and Geographic Information [Abstract]

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

Loss Per Share

12 Months Ended

Dec. 31, 2020

Loss Per Share [Abstract]

Loss Per Common Share

Note 17. Loss Per Share

The following table presents the reconciliation of the numerator and denominator for calculating loss per share from net loss (in thousands, except per share data):


	Year Ended December 31,
	2020		2019		2018
Numerator
Net loss	$	(39,106)	$	(22,818)	$	(185,231)
Less: income attributable to non-controlling interest		18,493		10,005		5,086
Net loss attributable to NCS Multistage Holdings, Inc.	$	(57,599)	$	(32,823)	$	(190,317)

Denominator
Basic weighted average number of shares (1)		2,364		2,332		2,239
Dilutive effect of other equity awards		—		—		—
Diluted weighted average number of shares (1)		2,364		2,332		2,239

Loss per common share
Basic (1)	$	(24.37)	$	(14.08)	$	(85.00)
Diluted (1)	$	(24.37)	$	(14.08)	$	(85.00)

Potentially dilutive securities excluded as anti-dilutive (1)		221		213		178

________________

(1)

Amounts in 2019 and 2018 have been retrospectively adjusted for the 1-for-20 reverse stock split that was effective on December 1, 2020.

Segment and Geographic Information

12 Months Ended

Dec. 31, 2020

Segment and Geographic Information

Note 18. Segment and Geographic Information

We have determined that we operate in one reportable segment that has been identified based on how our chief operating decision maker manages our business (see “Note 1. Organization and Basis of Presentation”).

Revenue by country for 2020, 2019 and 2018 is attributed based on the current billing address of the customer. The following table summarizes revenue by geographic area (in thousands):


	Year Ended December 31,
	2020		2019		2018
United States
Product sales	$	38,866	$	79,128	$	67,458
Services		7,313		24,163		35,984
Total United States		46,179		103,291		103,442
Canada
Product sales		34,330		59,895		80,871
Services		14,219		26,668		28,607
Total Canada		48,549		86,563		109,478
Other Countries
Product sales		2,001		6,803		8,452
Services		10,248		8,828		5,591
Total Other Countries		12,249		15,631		14,043
Total
Product sales		75,197		145,826		156,781
Services		31,780		59,659		70,182
Total revenues	$	106,977	$	205,485	$	226,963

The following table summarizes long-lived assets by geographic area (in thousands):


	December 31,		December 31,
	2020		2019
United States	$	16,616	$	18,137
Canada		10,356		17,831
Other Countries		2,633		2,077
	$	29,605	$	38,045

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

COVID-19 Pandemic Impacts

Quarterly Financial Data

12 Months Ended

Dec. 31, 2020

Quarterly Financial Data [Abstract]

Quarterly Financial Data

Note 19. Quarterly Financial Data (Unaudited)

The table below sets forth unaudited financial information for each quarter of the last two years (in thousands, except per share amounts):


	First		Second		Third		Fourth
	Quarter		Quarter		Quarter		Quarter
2020
Revenue	$	54,550	$	8,732	$	16,312	$	27,383
Cost of sales		30,614		6,393		10,208		15,692
Gross profit (1)		22,937		1,695		5,595		11,121
Impairments		50,194		—		—		—
Loss from operations		(49,678)		(14,232)		(7,473)		(57)
Gain on patent infringement settlement		—		—		—		25,678
Net (loss) income		(48,907)		(8,892)		(5,137)		23,830
Net (loss) income attributable to NCS Multistage Holdings, Inc.		(51,549)		(8,757)		(5,863)		8,570
(Loss) earnings per common share
Basic (2)	$	(21.92)	$	(3.70)	$	(2.48)	$	3.62
Diluted (2)	$	(21.92)	$	(3.70)	$	(2.48)	$	3.59

2019
Revenue	$	52,850	$	39,768	$	60,773	$	52,094
Cost of sales		26,763		23,081		32,209		25,977
Gross profit (1)		25,139		15,671		27,562		25,106
Impairments		—		7,919		—		—
Income (loss) from operations		437		(16,757)		5,509		1,320
Net (loss) income		(9,878)		(19,568)		6,609		19
Net (loss) income attributable to NCS Multistage Holdings, Inc.		(11,966)		(22,301)		3,621		(2,177)
(Loss) earnings per common share
Basic (2)	$	(5.20)	$	(9.54)	$	1.54	$	(0.93)
Diluted (2)	$	(5.20)	$	(9.54)	$	1.54	$	(0.93)

___________________________________________

(1)

Gross profit is defined as total revenue less cost of sales less depreciation and amortization attributed to cost of sales.

(2)

The sum of the individual quarterly earnings per share amounts may not agree with the annual amount reported as each quarterly computation is based on the weighted average number of common shares outstanding during the period. Amounts for the first three quarters of 2020 and all quarters in 2019 have been retrospectively adjusted for the 1-for-20 reverse stock split that was effective on December 1, 2020.

Organization and Basis of Presentation (Policy)	12 Months Ended
Organization and Basis of Presentation (Policy)	Dec. 31, 2020
Organization and Basis of Presentation [Abstract]
Organization	Organization NCS Multistage Holdings, Inc., a Delaware corporation, through its wholly owned subsidiaries and subsidiaries for which it has a controlling voting interest (collectively referred to as the “Company,” “NCS,” “we,” “our” and “us”), is primarily engaged in providing engineered products and support services for oil and natural gas well completions and field development strategies. We offer our products and services primarily to exploration and production companies for use in onshore wells. We operate through service facilities principally located in Houston and Odessa, Texas; Tulsa, Oklahoma; Billings, Montana; Morgantown, West Virginia; Calgary, Red Deer, Grande Prairie and Estevan, Canada; Neuquén, Argentina and Stavanger, Norway.
Basis of Presentation	Basis of Presentation Our accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). All intercompany transactions have been eliminated in consolidation. As NCS has the controlling voting interest in Repeat Precision, LLC (“Repeat Precision”), the other party’s ownership percentage is presented separately as a non-controlling interest. Certain reclassifications have been made to conform 2019 balances to our 2020 presentation on the consolidated balance sheets.
Reverse Stock Split and Authorized Share Reduction	Reverse Stock Split and Authorized Share Reduction On December 1, 2020, NCS implemented a reverse stock split of our shares of common stock in a ratio of 1-for-20 (the “reverse stock split”) with no reduction in the shares of preferred stock outstanding, and no change in the par value of the common and preferred stock. Unless specified otherwise, all common stock share amounts disclosed in this Annual Report on Form 10-K (“Form 10-K”) referencing a period prior to the reverse stock split have been adjusted to reflect this reverse stock split for all periods presented. In addition, our certificate of incorporation was amended to decrease our authorized capital stock to consist of 11,250,000 shares of common stock. Our authorized shares of preferred stock remained 10,000,000 shares. See “Note 12. Stockholders’ Equity” for additional information.

Summary of Significant Accounting Policies (Policy)

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Use of Estimates

Foreign Currency

Revenue Recognition

The payment terms and conditions in our customer contracts vary. We do not have contracts that contain a financing component and do not accept noncash consideration from customers.

NCS has elected to recognize shipping and handling costs when control of the product transfers to the customer. These costs are included in cost of sales in our consolidated statements of operations.

Product Sales Revenues

Services Revenues

Cash and Cash Equivalents

We consider all highly liquid instruments purchased with an original maturity date of three months or less to be cash equivalents. These items are carried at cost, which approximates fair value.

Concentration of Credit Risk

Accounts Receivable, Trade and Allowance for Doubtful Accounts

Trade accounts receivable are recorded at their invoiced amounts and do not bear interest. We perform ongoing credit evaluations of our clients and monitor collections and payments.

Inventories

Impairments

Property and Equipment



	Years
Buildings	30
Building equipment and leasehold improvements	1-15
Machinery and equipment and service equipment	5-12
Computers and software	3-5
Furniture and fixtures	3-5
Vehicles	2-4
Right of use assets - finance leases	Lease term (3-10)

Business Combinations, Goodwill and Intangible Assets

Costs related to the acquisition, other than those associated with the issuance of debt or equity securities, that we incur in connection with a business combination are expensed as incurred.

Income Taxes

Share-Based Compensation

Fair Value

Level 1—inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date;

Level 2—inputs other than quoted prices included within Level 1 that are observable for the assets or liability, either directly or indirectly; and

Level 3—inputs are unobservable for the asset or liability, which reflect the best judgment of management.

Severance and Other Termination Benefits

Earnings Per Share

Research and Development

Recent Accounting Pronouncements

Pronouncements Adopted in 2020

Pronouncements Not Yet Effective

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2020

Summary of Significant Accounting Policies [Abstract]

Property and Equipment Estimated Useful Service Lives or Lease Term



	Years
Buildings	30
Building equipment and leasehold improvements	1-15
Machinery and equipment and service equipment	5-12
Computers and software	3-5
Furniture and fixtures	3-5
Vehicles	2-4
Right of use assets - finance leases	Lease term (3-10)

Revenues (Tables)

12 Months Ended

Dec. 31, 2020

Revenues [Abstract]

Schedule of Contract Liabilities


Balance at December 31, 2018	$	515
Additions		104
Revenue recognized		(560)
Balance at December 31, 2019	$	59
Additions		—
Revenue recognized		(8)
Balance at December 31, 2020	$	51

Inventories, Net (Tables)

12 Months Ended

Dec. 31, 2020

Inventories, Net [Abstract]

Schedule of Inventories


	December 31,		December 31,
	2020		2019
Raw materials	$	1,752	$	1,986
Work in process		287		523
Finished goods		32,832		37,412
Total inventories, net	$	34,871	$	39,921

Other Current Receivables (Tables)

12 Months Ended

Dec. 31, 2020

Other Current Receivables [Abstract]

Schedule of Other Current Receivables


	December 31,		December 31,
	2020		2019
Current income tax receivables	$	6,295	$	4,777
Employee receivables		544		5
Other receivables		1,519		246
Total other receivables, net	$	8,358	$	5,028

Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2020

Property and Equipment [Abstract]

Schedule of Property and Equipment by Major Asset Class



	December 31,		December 31,
	2020		2019
Land	$	1,695	$	2,090
Building and improvements		8,511		12,242
Machinery and equipment		18,211		21,469
Computers and software		2,374		2,694
Furniture and fixtures		1,150		1,208
Vehicles		442		646
Right of use assets - finance leases		8,020		5,739
Service equipment		244		244
		40,647		46,332
Less: Accumulated depreciation and amortization		(16,312)		(14,333)
		24,335		31,999
Construction in progress		100		975
Property and equipment, net	$	24,435	$	32,974

Schedule of Depreciation Expense Associated Income Statement Line Items


	Year Ended December 31,
	2020		2019		2018
Cost of sales
Cost of product sales	$	1,679	$	2,711	$	2,003
Cost of services		1,043		1,266		1,070
Selling, general and administrative expenses		1,704		1,900		1,674
Total depreciation	$	4,426	$	5,877	$	4,747

Goodwill and Identifiable Intangibles (Tables)

12 Months Ended

Dec. 31, 2020

Goodwill and Identifiable Intangibles [Abstract]

Changes in Carrying Amount of Goodwill



	Gross Value		Accumulated Impairment		Net
Balance at December 31, 2018	$	177,115	$	(154,003)	$	23,112
Impairments		—		(7,937)		(7,937)
Currency translation adjustment		47		—		47
Balance at December 31, 2019	$	177,162	$	(161,940)	$	15,222
Impairments		—		—		—
Balance at December 31, 2020	$	177,162	$	(161,940)	$	15,222

Schedule of Identifiable Intangibles



		December 31, 2020
	Estimated	Gross
	Useful	Carrying		Accumulated		Net
	Lives (Years)	Amount		Amortization		Balance
Technology	1 - 20	$	3,958	$	(87)	$	3,871
Customer relationships	10		4,100		(1,606)		2,494
Total amortizable intangible assets		$	8,058	$	(1,693)	$	6,365
Technology - not subject to amortization	Indefinite		48		—		48
Total identifiable intangibles		$	8,106	$	(1,693)	$	6,413



		December 31, 2019
	Estimated	Gross
	Useful	Carrying		Accumulated		Net
	Lives (Years)	Amount		Amortization		Balance
Technology	8 - 18	$	17,721	$	(2,380)	$	15,341
Trademarks	5 - 10		1,600		(373)		1,227
Customer relationships	10 - 21		28,689		(3,928)		24,761
Internally developed software	5		4,904		(985)		3,919
Total identifiable intangibles		$	52,914	$	(7,666)	$	45,248

Schedule of Estimated Future Amortization Expense


2021	$	669
2022		669
2023		669
2024		669
2025		669
Thereafter		3,020
Total	$	6,365

Accrued Expenses (Tables)

12 Months Ended

Dec. 31, 2020

Accrued Expenses [Abstract]

Schedule of Accrued Expenses



	December 31,		December 31,
	2020		2019
Accrued payroll and bonus	$	999	$	2,558
Property and franchise taxes accrual		505		462
Severance and other termination benefits (Note 11)		730		—
Accrued other miscellaneous liabilities		1,113		431
	$	3,347	$	3,451

Debt (Tables)

12 Months Ended

Dec. 31, 2020

Debt [Abstract]

Schedule of Long-term Debt



	December 31,		December 31,
	2020		2019
Senior Secured Credit Facility	$	—	$	10,000
Finance leases		5,789		2,917
Total debt		5,789		12,917
Less: current portion		(1,347)		(1,481)
Long-term debt	$	4,442	$	11,436

Severance and Other Termination Benefits (Tables)

12 Months Ended

Dec. 31, 2020

Severance and Other Termination Benefits [Abstract]

Schedule of Reconciliation of Beginning and Ending Liability Balance


Beginning balance, December 31, 2019	$	—
Additions for costs expensed		5,661
Severance payments		(4,969)
Currency translation adjustment		38
Ending balance, December 31, 2020	$	730

Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2020

Summary of Stock Option Activity



2012 Equity Plan and 2017 Equity Plan	Service Based Options	Liquidity Options	Total Options	Service Based Weighted Average Exercise Price		Liquidity Based Weighted Average Exercise Price		Service Based Weighted Average Remaining Contractual Life (Years)	Liquidity Weighted Average Remaining Contractual Life (Years)
Outstanding at December 31, 2019	42,752	63,411	106,163	$	122.39	$	123.14	3.22	3.16
Granted during the year	—	—	—		—		—
Exercised during the year	(675)	—	(675)		0.20		—
Forfeited during the year	(150)	(1,109)	(1,259)		191.20		149.99
Expired during the year	(2,425)	(3,720)	(6,145)		122.67		147.69
Outstanding at December 31, 2020	39,502	58,582	98,084	$	124.20	$	121.07	2.11	2.07
Unvested as of December 31, 2020	125	—	125		193.40		—
Exercisable as of December 31, 2020	39,377	58,582	97,959	$	123.98	$	121.07	2.11	2.07

Summary of Share-Based Compensation Expense Recognized in Selling, General and Administrative Expense


	Year Ended December 31,
	2020		2019		2018
Stock options	$	1,459	$	5,263	$	5,865
Restricted stock units		3,921		5,032		3,672
Equivalent stock units		759		338		-
Performance stock unit awards		2,343		1,682		800
ESPP		-		227		593
Total share-based compensation expense	$	8,482	$	12,542	$	10,930
Related income tax benefit	$	92	$	157	$	1,698

Equivalent Stock Unit Awards [Member]

Summary of Stock Unit Activity


	Number of Awards	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2019	28,790	$	110.21
Granted	150,036		21.71
Vested	(9,609)		110.21
Forfeited	(34,425)		36.58
Non-vested at December 31, 2020	134,792	$	30.50

Performance Stock Unit Awards (PSUs) [Member]

Schedule of Weighted Average Assumptions Used to Estimate Fair Value of Awards


	2020			2019			2018
Grant date		February 28, 2020			February 28, 2019			March 1, 2018
Performance period		January 1, 2020 to December 31, 2022			January 1, 2019 to December 31, 2021			January 1, 2018 to December 31, 2020
Volatility		70.7	%		63.2	%		54.3	%
Risk-free interest rate		0.9	%		2.5	%		2.3	%
Expected dividends		—	%		—	%		—	%
Grant date price	$	21.80		$	110.20		$	290.60
Weighted-average fair value per share	$	26.20		$	130.00		$	347.40

Summary of Stock Unit Activity


	Number of Awards	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2019	26,684	$	193.80
Granted	51,806		26.20
Vested	—		—
Forfeited	(7,821)		347.61
Non-vested at December 31, 2020	70,669	$	53.91

2017 Plan [Member] | Restricted Stock Units (RSUs) [Member]

Summary of Stock Unit Activity


	Number of Awards	Weighted Average Grant Date Fair Value
Non-vested at December 31, 2019	66,819	$	158.61
Granted	25,047		22.11
Vested (including 4,371 shares that have not been released)	(30,401)		166.84
Forfeited	(12,434)		121.81
Non-vested at December 31, 2020	49,031	$	93.11

Employee Stock Purchase Plan (ESPP) [Member]

Schedule of Weighted Average Assumptions Used to Estimate Fair Value of Awards


	January 1, 2019 to June 30, 2019			October 16, 2017 to December 31, 2018
Expected volatility		82.8	%		38.8	%
Average risk-free interest rate		2.5	%		1.4	%
Expected dividends		—	%		—	%
Weighted-average fair value per share	$	40.40		$	143.20

Leases (Tables)

12 Months Ended

Dec. 31, 2020

Leases [Abstract]

Supplemental Balance Sheet Information Related to Leases


			December 31,		December 31,
Leases	Consolidated Balance Sheet Classification		2020		2019
Assets
Operating	Operating lease assets	$	5,170	$	5,071
Finance (1)	Property and equipment, net		5,851		3,379
Total leased right-of-use assets		$	11,021	$	8,450

Liabilities
Current
Operating	Operating lease liabilities	$	1,826	$	2,052
Finance	Current maturities of long-term debt		1,347		1,481

Noncurrent
Operating	Operating lease liabilities, long-term		3,989		3,487
Finance	Long-term debt, less current maturities		4,442		1,436
Total lease liabilities		$	11,604	$	8,456

_______________

(1)

Finance lease right-of-use assets are recorded net of accumulated amortization of $2.2 million and $2.4 million as of December 31, 2020 and 2019, respectively.

Components of Lease Expense


		Year Ended December 31,
Lease Cost	Consolidated Statements of Operations Classification	2020		2019
Operating lease cost	Cost of sales; Selling, general and administrative expenses	$	2,193	$	2,891
Finance lease cost
Amortization of right-of-use assets	Depreciation		1,503		1,409
Interest on lease liabilities	Interest expense, net		300		257
Short-term lease cost	Cost of sales; Selling, general and administrative expenses		1,280		898
Total lease cost		$	5,276	$	5,455

Maturities of Lease Liabilities


Year Ending December 31,	Operating Leases		Finance Leases
2021	$	2,074	$	1,597
2022		1,335		1,274
2023		837		742
2024		744		493
2025		613		492
Thereafter		930		2,182
Total lease payments	$	6,533	$	6,780
Less: interest		718		991
Present value of lease liabilities	$	5,815	$	5,789

Lease Term and Discount Rate


	December 31,			December 31,
Lease Term and Discount Rate	2020			2019
Weighted-average remaining lease term (years):
Operating leases		4.1			2.9
Finance leases		7.2			1.6
Weighted-average discount rate:
Operating leases		5.4	%		5.9	%
Finance leases		4.9	%		5.5	%

Supplemental Cash Flow and Other Information Related to Leases


	Year Ended		Year Ended
	December 31,		December 31,
Other Information	2020		2019
Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	2,324	$	3,278
Operating cash flows from finance leases		300		257
Financing cash flows from finance leases		1,634		1,705

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2020

Income Taxes [Abstract]

Provision (Benefit) from Income Taxes


	Year Ended December 31,
	2020		2019		2018
Current tax expense (benefit)
U.S. Federal	$	(413)	$	(382)	$	1,241
State		(183)		221		240
Foreign		(3,985)		1,913		4,307
Total current		(4,581)		1,752		5,788
Deferred tax expense (benefit)
U.S. Federal	$	—	$	8,746	$	(9,525)
State		—		580		(599)
Foreign		(3,202)		(326)		(18,716)
Total deferred		(3,202)		9,000		(28,840)
Total income taxes	$	(7,783)	$	10,752	$	(23,052)

Domestic and Foreign Components of (Loss) Income Before Income Taxes


	Year Ended December 31,
	2020		2019		2018
U.S. Federal	$	(25,086)	$	(13,762)	$	(52,523)
Foreign		(21,803)		1,696		(155,760)
Loss before income tax	$	(46,889)	$	(12,066)	$	(208,283)

Summary of Items that Caused Recorded Income Taxes to Differ from Income Taxes Computed Using Statutory Federal Income Tax Rate


	Year Ended December 31,
	2020		2019		2018
Income tax at federal statutory rate	21.0	%	21.0	%	21.0	%
Increase (decrease) in income taxes resulting from
Impairment expense	-	%	(2.6)	%	(15.7)	%
Foreign taxes on U.S. income	2.6	%	(12.1)	%	-	%
Non-controlling interest gain/losses	6.7	%	15.7	%	0.5	%
U.S. tax on foreign earnings	(1.7)	%	(5.7)	%	1.5	%
Nondeductible expenses	1.2	%	(3.7)	%	(0.2)	%
Deductible foreign taxes	(0.1)	%	2.7	%	-	%
Non U.S. income taxed at different rates	3.2	%	(1.2)	%	4.5	%
Research and other tax credits	0.9	%	6.4	%	0.4	%
Effect of rate change on deferred tax	(0.7)	%	1.9	%	-	%
Stock-based compensation	(2.2)	%	(7.7)	%	(0.2)	%
State taxes	1.1	%	4.1	%	0.2	%
Change in valuation allowance	(16.9)	%	(108.6)	%	(0.5)	%
Other	1.5	%	0.7	%	(0.4)	%
Income tax	16.6	%	(89.1)	%	11.1	%

Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities


	December 31,
	2020		2019
Deferred tax assets
Accruals not currently deductible	$	6,579	$	6,076
Depreciation and amortization		12,019		5,097
Foreign tax credit carryforward		—		778
Tax loss carryforward		1,284		269
Other		2,735		2,074
		22,617		14,294
Valuation allowance for deferred tax assets		(22,312)		(14,226)
Total deferred tax assets		305		68
Deferred tax liabilities
Depreciation and amortization		—		(3,006)
Foreign currency translation		(78)		(7)
Other		(35)		(5)
Total deferred tax liabilities		(113)		(3,018)
Net deferred tax assets (liabilities)	$	192	$	(2,950)

The above are included in the accompanying consolidated balance sheet as follows (in thousands):


	December 31,
	2020		2019
Deferred income tax assets—noncurrent	$	205	$	6
Deferred income tax liabilities—noncurrent		(13)		(2,956)
	$	192	$	(2,950)

Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2020

Loss Per Share [Abstract]

Reconciliation of Numerator and Denominator for Calculating (loss) Earnings Per Share from Net (loss) Income


	Year Ended December 31,
	2020		2019		2018
Numerator
Net loss	$	(39,106)	$	(22,818)	$	(185,231)
Less: income attributable to non-controlling interest		18,493		10,005		5,086
Net loss attributable to NCS Multistage Holdings, Inc.	$	(57,599)	$	(32,823)	$	(190,317)

Denominator
Basic weighted average number of shares (1)		2,364		2,332		2,239
Dilutive effect of other equity awards		—		—		—
Diluted weighted average number of shares (1)		2,364		2,332		2,239

Loss per common share
Basic (1)	$	(24.37)	$	(14.08)	$	(85.00)
Diluted (1)	$	(24.37)	$	(14.08)	$	(85.00)

Potentially dilutive securities excluded as anti-dilutive (1)		221		213		178

Segment and Geographic Information (Tables)

12 Months Ended

Dec. 31, 2020

Segment and Geographic Information [Abstract]

Summary of Revenue and Long-Lived Assets by Geographical Area


	Year Ended December 31,
	2020		2019		2018
United States
Product sales	$	38,866	$	79,128	$	67,458
Services		7,313		24,163		35,984
Total United States		46,179		103,291		103,442
Canada
Product sales		34,330		59,895		80,871
Services		14,219		26,668		28,607
Total Canada		48,549		86,563		109,478
Other Countries
Product sales		2,001		6,803		8,452
Services		10,248		8,828		5,591
Total Other Countries		12,249		15,631		14,043
Total
Product sales		75,197		145,826		156,781
Services		31,780		59,659		70,182
Total revenues	$	106,977	$	205,485	$	226,963

The following table summarizes long-lived assets by geographic area (in thousands):


	December 31,		December 31,
	2020		2019
United States	$	16,616	$	18,137
Canada		10,356		17,831
Other Countries		2,633		2,077
	$	29,605	$	38,045

Quarterly Financial Data (Tables)

12 Months Ended

Dec. 31, 2020

Quarterly Financial Data [Abstract]

Quarterly Financial Data


	First		Second		Third		Fourth
	Quarter		Quarter		Quarter		Quarter
2020
Revenue	$	54,550	$	8,732	$	16,312	$	27,383
Cost of sales		30,614		6,393		10,208		15,692
Gross profit (1)		22,937		1,695		5,595		11,121
Impairments		50,194		—		—		—
Loss from operations		(49,678)		(14,232)		(7,473)		(57)
Gain on patent infringement settlement		—		—		—		25,678
Net (loss) income		(48,907)		(8,892)		(5,137)		23,830
Net (loss) income attributable to NCS Multistage Holdings, Inc.		(51,549)		(8,757)		(5,863)		8,570
(Loss) earnings per common share
Basic (2)	$	(21.92)	$	(3.70)	$	(2.48)	$	3.62
Diluted (2)	$	(21.92)	$	(3.70)	$	(2.48)	$	3.59

2019
Revenue	$	52,850	$	39,768	$	60,773	$	52,094
Cost of sales		26,763		23,081		32,209		25,977
Gross profit (1)		25,139		15,671		27,562		25,106
Impairments		—		7,919		—		—
Income (loss) from operations		437		(16,757)		5,509		1,320
Net (loss) income		(9,878)		(19,568)		6,609		19
Net (loss) income attributable to NCS Multistage Holdings, Inc.		(11,966)		(22,301)		3,621		(2,177)
(Loss) earnings per common share
Basic (2)	$	(5.20)	$	(9.54)	$	1.54	$	(0.93)
Diluted (2)	$	(5.20)	$	(9.54)	$	1.54	$	(0.93)

___________________________________________

(1)

Gross profit is defined as total revenue less cost of sales less depreciation and amortization attributed to cost of sales.

(2)

Organization and Basis of Presentation (Narrative) (Details) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 01, 2020	Nov. 30, 2020	Dec. 31, 2019
Organization and Basis of Presentation [Abstract]
Common stock, shares authorized (in shares)	11,250,000	11,250,000	225,000,000	11,250,000
Preferred stock, shares authorized (in shares)	10,000,000			10,000,000
Reverse stock split, description	1-for-20

Summary of Significant Accounting Policies (Narrative) (Details)		3 Months Ended									9 Months Ended	12 Months Ended
	Aug. 03, 2017	Dec. 31, 2020 USD ($)	Sep. 30, 2020 USD ($)	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)	Jun. 30, 2019 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 USD ($) customer	Dec. 31, 2019 USD ($) customer	Dec. 31, 2018 USD ($) customer
Revenues		$ 27,383,000	$ 16,312,000	$ 8,732,000	$ 54,550,000	$ 52,094,000	$ 60,773,000	$ 39,768,000	$ 52,850,000			$ 106,977,000	$ 205,485,000	$ 226,963,000
Provision for doubtful accounts		600,000				$ 500,000					$ 600,000	600,000	500,000
Impairments of property and equipment and finite-lived intangible assets												50,200,000	0
Impairment of identifiable intangible assets											0		0	73,500,000
Impairment charge of property and equipment													0	0
Goodwill impairment charge										$ 154,000,000		0	7,937,000	154,000,000
Employee-related liabilities		730,000									730,000	730,000
Research and development expense												$ 1,900,000	$ 2,800,000	$ 3,800,000
Impact of COVID -19 [Member]
Impairment charge of property and equipment					$ 9,700,000
Employee Stock Purchase Plan (ESPP) [Member]
Purchase price of common stock expressed as a percentage of its fair value	85.00%											85.00%
Trade Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Number of customers \| customer												1	1
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Number of customers \| customer												1	0	0
One-time Termination Benefits [Member]
One-time cash severance costs												$ 5,700,000
Employee-related liabilities		$ 700,000									$ 700,000	700,000
One-time Termination Benefits [Member] \| Impact of COVID -19 [Member]
One-time cash severance costs												$ 5,700,000
Customer One [Member] \| Trade Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration risk, percentage												12.00%	10.00%
Customer One [Member] \| Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Concentration risk, percentage														10.00%
Revenues														$ 10,200,000

Summary of Significant Accounting Policies (Property and Equipment Estimated Useful Service Lives or Lease Term) (Details)	12 Months Ended
	Dec. 31, 2020
Building [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	30 years
Maximum [Member] \| Building Equipment and Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	15 years
Maximum [Member] \| Machinery and Equipment and Service Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	12 years
Maximum [Member] \| Computer and software [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	5 years
Maximum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	5 years
Maximum [Member] \| Vehicles [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	4 years
Maximum [Member] \| Right Of Use Assets - Finance Leases [Member]
Property, Plant and Equipment [Line Items]
Lease term	10 years
Minimum [Member] \| Building Equipment and Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	1 year
Minimum [Member] \| Machinery and Equipment and Service Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	5 years
Minimum [Member] \| Computer and software [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	3 years
Minimum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	3 years
Minimum [Member] \| Vehicles [Member]
Property, Plant and Equipment [Line Items]
Useful service lives	2 years
Minimum [Member] \| Right Of Use Assets - Finance Leases [Member]
Property, Plant and Equipment [Line Items]
Lease term	3 years

Revenues (Narrative) (Details) $ in Thousands	12 Months Ended
Revenues (Narrative) (Details) $ in Thousands	Dec. 31, 2020 USD ($) item	Dec. 31, 2019 USD ($) item	Dec. 31, 2018 USD ($) item
Revenues [Abstract]
Revenue recognized from the contract liability balance \| $	$ (8)	$ (560)	$ 500
Percentage of product and service revenues single performance obligation	99.00%	99.00%	99.00%
Percentage of self-service product line revenues performance obligation	1.00%	1.00%	1.00%
Number of performance obligations associated with self-service product line	2	2	2
Number of performance obligations in self-service product line revenue	2	2	2
Revenue performance obligation product and services description	Approximately 99% of our product and service revenues are considered a single performance obligation. Our self-service product line, which is approximately one percent of our revenue for the years ended December 31, 2020, 2019 and 2018 is made up of two performance obligations: (i) the delivery of tracer materials to a customer well site and (ii) the creation of diagnostic reports ordered by customers when we do not perform an integrated service. For these contracts, we do not allocate the transaction price as the individual performance obligations are sold at standalone prices in the customer order. The transaction prices for our self-service product line that have two performance obligations are (i) the price per unit times the quantity of tracer materials and (ii) prices charged for diagnostic reports ordered by and delivered to the customer.

Revenues (Schedule of Contract Liabilities) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Current Contract Liability [Abstract]
Contract Liabilities Current Beginning Balance	$ 59	$ 515
Additions		104
Revenue recognized	(8)	(560)	$ 500
Contract Liabilities Current Ending Balance	$ 51	$ 59	$ 515

Inventories, Net (Schedule of Inventories) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Inventories, Net [Abstract]
Raw materials	$ 1,752	$ 1,986
Work in process	287	523
Finished goods	32,832	37,412
Total inventories, net	$ 34,871	$ 39,921

Other Current Receivables (Schedule Of Other Current Receivables) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Other Current Receivables [Abstract]
Current income tax receivables	$ 6,295	$ 4,777
Employee receivables	544	5
Other receivables	1,519	246
Total other receivables, net	$ 8,358	$ 5,028

Property and Equipment (Narrative) (Details) - USD ($)	3 Months Ended	12 Months Ended
Property and Equipment (Narrative) (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Impairment charge of property and equipment		$ 0	$ 0
Impact of COVID -19 [Member]
Property, Plant and Equipment [Line Items]
Impairment charge of property and equipment	$ 9,700,000

Property and Equipment (Schedule of Property and Equipment by Major Asset Class) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property and equipment	$ 40,647	$ 46,332
Less: Accumulated depreciation and amortization	(16,312)	(14,333)
Property and equipment, net, excluding construction in progress	24,335	31,999
Construction in progress	100	975
Property and equipment, net	24,435	32,974
Land [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	1,695	2,090
Building and Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	8,511	12,242
Machinery and Equipment and Service Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	18,211	21,469
Computer and software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	2,374	2,694
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	1,150	1,208
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	442	646
Right Of Use Assets - Finance Leases [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	8,020	5,739
Service Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	$ 244	$ 244

Property and Equipment (Schedule of Depreciation Expense Associated Income Statement Line Items) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Depreciation expense	$ 4,426	$ 5,877	$ 4,747
Cost of product sales [Member]
Depreciation expense	1,679	2,711	2,003
Cost of services [Member]
Depreciation expense	1,043	1,266	1,070
Selling, general and administrative expenses [Member]
Depreciation expense	$ 1,704	$ 1,900	$ 1,674

Goodwill and Identifiable Intangibles (Narrative) (Details)	3 Months Ended			9 Months Ended	12 Months Ended
	Mar. 31, 2020 USD ($)	Jun. 30, 2019 USD ($)	Dec. 31, 2018 USD ($) segment	Dec. 31, 2020 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($) segment
Goodwill [Line Items]
Number of reporting units \| segment			2				3
Goodwill impairment charge			$ 154,000,000		$ 0	$ 7,937,000	$ 154,000,000
Goodwill, gross			177,115,000	$ 177,162,000	177,162,000	177,162,000	177,115,000
Goodwill			23,112,000	15,222,000	15,222,000	15,222,000	23,112,000
Finite-lived intangible assets impairment charge				$ 0		0	73,500,000
Amortization expense					$ 1,465,000	4,559,000	$ 13,090,000
Weighted average amortization period					13 years
Fracturing Systems and Well Construction [Member]
Goodwill [Line Items]
Finite-lived intangible assets impairment charge			$ 73,500,000
Tracer Diagnostic Services [Member]
Goodwill [Line Items]
Goodwill impairment charge		$ 7,900,000
Goodwill		$ 0
Repeat Precision [Member]
Goodwill [Line Items]
Goodwill impairment charge						0
Goodwill, gross						$ 15,200,000
Repeat Precision [Member] \| Settlement Agreement with Diamondback and Derrek [Member]
Goodwill [Line Items]
Increase in intangible assets related to transfer of patent					$ 3,800,000
Technology and Internally-Developed Software [Member] \| Impact of COVID -19 [Member] \| Fracturing Systems and Well Construction [Member]
Goodwill [Line Items]
Finite-lived intangible assets impairment charge	$ 11,900,000
Customer Relationships, Technology, Internally Developed Software And Trademarks [Member] \| Impact of COVID -19 [Member] \| Tracer Diagnostic Services [Member]
Goodwill [Line Items]
Finite-lived intangible assets impairment charge	$ 28,600,000

Goodwill and Identifiable Intangibles (Changes in Carrying Amount of Goodwill) (Details) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Goodwill and Identifiable Intangibles [Abstract]
Goodwill gross beginning balance		$ 177,162,000	$ 177,115,000
Goodwill gross, Impairment		0
Goodwill gross, Currency translation adjustment			47,000
Goodwill gross ending balance	$ 177,115,000	177,162,000	177,162,000	$ 177,115,000
Accumulated Impairment beginning balance		(161,940,000)	(154,003,000)
Accumulated impairment, Impairment	(154,000,000)	0	(7,937,000)	(154,000,000)
Accumulated Impairment ending balance	(154,003,000)	(161,940,000)	(161,940,000)	(154,003,000)
Goodwill net beginning balance		15,222,000	23,112,000
Goodwill net, Impairment			(7,937,000)
Goodwill net, Currency translation adjustment			47,000
Goodwill net ending balance	$ 23,112,000	$ 15,222,000	$ 15,222,000	$ 23,112,000

Goodwill and Identifiable Intangibles (Schedule of Identifiable Intangibles) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Carrying Amount	$ 8,058	$ 52,914
Finite-lived intangible assets, Accumulated Amortization	(1,693)	(7,666)
Finite-lived intangible assets, Net Balance	6,365	45,248
Intangible Assets, Gross (Excluding Goodwill), Total	8,106
Intangible Assets, Net (Excluding Goodwill), Total	6,413	45,248
Technology Not Subject To Amortization [Member]
Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	48
Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Carrying Amount	3,958	17,721
Finite-lived intangible assets, Accumulated Amortization	(87)	(2,380)
Finite-lived intangible assets, Net Balance	$ 3,871	$ 15,341
Technology [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	1 year	8 years
Technology [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	20 years	18 years
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Carrying Amount		$ 1,600
Finite-lived intangible assets, Accumulated Amortization		(373)
Finite-lived intangible assets, Net Balance		$ 1,227
Trademarks [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life		5 years
Trademarks [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life		10 years
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	10 years
Finite-lived intangible assets, Gross Carrying Amount	$ 4,100	$ 28,689
Finite-lived intangible assets, Accumulated Amortization	(1,606)	(3,928)
Finite-lived intangible assets, Net Balance	$ 2,494	$ 24,761
Customer Relationships [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life		10 years
Customer Relationships [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life		21 years
Internally Developed Software [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life		5 years
Finite-lived intangible assets, Gross Carrying Amount		$ 4,904
Finite-lived intangible assets, Accumulated Amortization		(985)
Finite-lived intangible assets, Net Balance		$ 3,919

Goodwill and Identifiable Intangibles (Schedule of Estimated Future Amortization Expense) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Identifiable Intangibles [Abstract]
Finite-lived intangible assets, amortization expense, 2021	$ 669
Finite-lived intangible assets, amortization expense, 2022	669
Finite-lived intangible assets, amortization expense, 2023	669
Finite-lived intangible assets, amortization expense, 2024	669
Finite-lived intangible assets, amortization expense, 2025	669
Finite-lived intangible assets, amortization expense, thereafter	3,020
Finite-lived intangible assets, Net Balance	$ 6,365	$ 45,248

Accrued Expenses (Schedule of Accrued Expenses) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Accrued Expenses [Abstract]
Accrued payroll and bonus	$ 999	$ 2,558
Property and franchise taxes accrual	505	462
Severance and other termination benefits (Note 11)	730
Accrued other miscellaneous liabilities	1,113	431
Total accrued expenses	$ 3,347	$ 3,451

Debt (Narrative) (Details)					3 Months Ended		12 Months Ended
Debt (Narrative) (Details)	Aug. 06, 2020 USD ($)	Aug. 05, 2020 USD ($)	Apr. 30, 2020 USD ($)	Feb. 27, 2017 USD ($)	Sep. 30, 2020 USD ($)	Jun. 30, 2019	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Feb. 16, 2018 USD ($)
Debt Instrument [Line Items]
Expensed deferred loan costs							$ 606,000
Amortization expense of deferred financing charges							296,000	$ 312,000	$ 334,000
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Debt instrument, fair value							5,600,000	12,500,000
Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 75,000,000
Debt issuance cost net								900,000
Unamortized deferred costs								300,000
Amortization expense of deferred financing charges							300,000	200,000
Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member] \| Revolving Credit U.S. Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity		50,000,000
Line of credit outstanding							0	10,000,000
Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member] \| Revolving Credit Canadian Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 25,000,000
Senior Secured Credit Facility [Member] \| Minimum [Member] \| If Leverage Ratio as of End of Any Fiscal Quarter is Greater than 2.00 to 1.00 and the Amount Outstanding Under the Canadian Facility at Any Time During such Fiscal Quarter was Greater than $0 [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Asset coverage ratio		1.00%
Senior Secured Credit Facility [Member] \| Minimum [Member] \| If Leverage Ratio as of End of Any Fiscal Quarter is Greater than 2.00 to 1.00 and Amount Outstanding Under U.S. Facility at Any Time During such Fiscal Quarter was Greater than $0 [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Asset coverage ratio		1.00%
Senior Secured Credit Facility [Member] \| Maximum [Member] \| Commencing on Quarter Ending June 30, 2019 through Last Day of Each Fiscal Quarter [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Leverage ratio						2.50%
Interest coverage ratio		2.75%
Promissory Note [Member] \| Repeat Precision [Member] \| February 2017 Note [Member]
Debt Instrument [Line Items]
Debt instrument, maximum borrowing capacity				$ 3,800,000						$ 4,300,000
Long-term debt, gross							$ 0	0
Debt instrument variable interest rate				1.00%
Debt maturity date							Feb. 12, 2022
Promissory Note [Member] \| Repeat Precision [Member] \| April 2020 Note [Member]
Debt Instrument [Line Items]
Debt instrument, maximum borrowing capacity			$ 5,000,000
Long-term debt, gross							$ 0
Debt instrument variable interest rate			1.00%
Debt maturity date							Apr. 30, 2021
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 25,000,000
Debt maturity date							May 01, 2023
Interest expense including commitment fees							$ 600,000
Unamortized deferred costs	600,000
Expensed deferred loan costs					$ 600,000
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member] \| Base Rate [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate							4.375%
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Debt instrument, borrowing base							$ 11,000,000
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member] \| Revolving Credit U.S. Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	25,000,000
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member] \| Revolving Credit Canadian Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	0
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member] \| Letter of Credit [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	2,500,000
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Wells Fargo Bank [Member] \| Swingline Loans [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	2,500,000
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Minimum [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate							2.75%
Minimum liquidity amount required under new financial covenants	$ 7,500,000
Fixed charge coverage ratio	1.0
Cash availabilty on last business day of each week	$ 12,000,000
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Minimum [Member] \| Monthly Availability [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Percentage of availability in relation to the borrowing base	12.00%
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Maximum [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate	3.75%
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Maximum [Member] \| Weekly Availability [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Percentage of availability in relation to the borrowing base	12.00%
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Maximum [Member] \| Quarterly Availability [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Percentage of availability in relation to the borrowing base	20.00%
Amendment [Member] \| Senior Secured Credit Facility [Member] \| Repeat Precision [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Maximum indebtedness amount for unrestricted subsidiary	$ 10,000,000
Amendment [Member] \| Senior Secured Credit Facility, Sublimit [Member] \| Wells Fargo Bank [Member]
Debt Instrument [Line Items]
Interest expense including commitment fees								$ 700,000
Amendment [Member] \| Senior Secured Credit Facility, Sublimit [Member] \| Wells Fargo Bank [Member] \| Revolving Credit Canadian Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 15,000,000

Debt (Schedule of Long-term Debt) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Total debt	$ 5,789	$ 12,917
Less: current portion	(1,347)	(1,481)
Long-term debt	4,442	11,436
Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Total debt		10,000
Finance Leases [Member]
Debt Instrument [Line Items]
Total debt	$ 5,789	$ 2,917

Commitments and Contingencies (Narrative) (Details) - USD ($) $ in Thousands		1 Months Ended		3 Months Ended								12 Months Ended
	Apr. 03, 2020	Oct. 31, 2020	Apr. 30, 2020	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Loss Contingencies [Line Items]
Gain on patent infringement settlement				$ 25,678								$ 25,678
Revenues				27,383	$ 16,312	$ 8,732	$ 54,550	$ 52,094	$ 60,773	$ 39,768	$ 52,850	106,977	$ 205,485	$ 226,963
Other income, net												1,729	$ 308	$ 182
Repeat Precision [Member]
Loss Contingencies [Line Items]
Loss contingency damages awarded value	$ 39,900
Repeat Precision [Member] \| Settlement Agreement with Diamondback and Derrek [Member]
Loss Contingencies [Line Items]
Proceeds received from insurance			$ 1,100
Upfront cash payment		$ 15,500
Period to receive secured note receivable		2 years
Payment for certain setting tool sold by Diamondback as a restitution		$ 5,000
Additional amount due from legal settlement recorded as a note receivable		$ 5,000
Gain on patent infringement settlement												25,700
Legal fees incurred												$ 2,700
Special Oilfield Services Co. LLC [Member]
Loss Contingencies [Line Items]
Percentage of withholding tax on profit payable												10.00%
Amount receivable associated with profit sharing provision of collaboration arrangement pursuant to contractual terms				$ 1,100								$ 1,100
Withholding tax on profit-share												100
Special Oilfield Services Co. LLC [Member] \| Tracer Diagnostic Services [Member]
Loss Contingencies [Line Items]
Revenues												1,600
Other income, net												$ 900

Severance and Other Termination Benefits (Narrative) (Details) - One-time Termination Benefits [Member] $ in Thousands			1 Months Ended	12 Months Ended
	Apr. 04, 2020 employee	Apr. 01, 2020 employee	Jul. 31, 2020 employee	Dec. 31, 2020 USD ($)
Restructuring Cost and Reserve [Line Items]
One-time cash severance costs				$ 5,700
Impact of COVID -19 [Member]
Restructuring Cost and Reserve [Line Items]
Number of workforce reduced \| employee	50	80	50
One-time cash severance costs				$ 5,700

Severance and Other Termination Benefits (Schedule of Reconciliation of Beginning and Ending Liability Balance) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($)
Severance and Other Termination Benefits [Abstract]
Beginning balance
Additions for costs expensed	5,661
Severance payments	(4,969)
Currency translation adjustment	38
Ending balance	$ 730

Stockholders' Equity (Narrative) (Details)	12 Months Ended
Stockholders' Equity (Narrative) (Details)	Dec. 31, 2020 item $ / shares shares	Dec. 31, 2019 $ / shares shares	Dec. 01, 2020 shares	Nov. 30, 2020 shares	Oct. 27, 2020 shares
Equity, Class of Treasury Stock [Line Items]
Reverse stock split, description	1-for-20
Common stock, shares outstanding (in shares)	2,359,918	2,340,656
Common stock, shares authorized (in shares)	11,250,000	11,250,000	11,250,000	225,000,000
Voting rights entitled for each common stockholders	The holders of common stock are entitled to one vote for each share of common stock held.
Voting right for each share of common stock held \| item	1
Dividends declared \| $ / shares	$ 0	$ 0
Advent International Corporation [Member]
Equity, Class of Treasury Stock [Line Items]
Reverse stock split, description	1-for-20
Common stock, shares outstanding (in shares)					29,568,536
Beneficially held shares of common stock percent					62.60%

Share-Based Compensation (Narrative) (Details)		1 Months Ended		3 Months Ended	12 Months Ended
Share-Based Compensation (Narrative) (Details)	Aug. 03, 2017 USD ($) shares	Jul. 31, 2019 shares	Jan. 31, 2019 shares	Jun. 30, 2017 item employee	Dec. 31, 2020 USD ($) item $ / shares shares	Dec. 31, 2019 USD ($) shares	Dec. 31, 2018 USD ($)
Employee Stock Option [Member]
Number of employees for which liquidity awards were amended in connection with IPO \| employee				22
Total intrinsic value of options exercised \| $					$ 6,000		$ 9,800,000
Unrecognized compensation cost related to options \| $					6,000
Number of vesting equal annual installments \| item				3
Income tax benefit realized from compensation expense \| $					$ 1,000		500,000
Employee Stock Option [Member] \| Minimum [Member]
Share-based compensation cost recognition weighted average period					1 year
Restricted Stock Units (RSUs) [Member]
Share-based compensation shares granted					25,047
Weighted average grant date fair value \| $ / shares					$ 22.11
Share-based compensation cost not yet recognized share-based awards Other than options \| $					$ 1,700,000
Income tax benefit realized from compensation expense \| $					100,000	$ 200,000	100,000
Total value of shares vested and released \| $					$ 500,000	$ 1,000,000	$ 600,000
Restricted Stock Units (RSUs) [Member] \| Maximum [Member]
Number of vesting equal annual installments \| item					3
Equivalent Stock Units (ESUs) [Member]
Number of vesting equal annual installments \| item					3
Payments made upon settlement of the ESUs \| $					$ 200,000
Share-based compensation arrangement, liability \| $					$ 900,000
Performance Stock Unit Awards (PSUs) [Member]
Share-based compensation cost recognition weighted average period					3 years
Share-based compensation cost not yet recognized share-based awards Other than options \| $					$ 1,700,000
Performance Stock Unit Awards (PSUs) [Member] \| Minimum [Member]
Number of common stock shares issued for each PSU					0
Share-based compensation cost recognition weighted average period					2 years
Performance Stock Unit Awards (PSUs) [Member] \| Maximum [Member]
Number of common stock shares issued for each PSU					2
Performance Stock Unit Awards (PSUs) [Member] \| 50th percentile relative TSR [Member]
Share-based compensation arrangement performance obligations, percentage					65.00%
Performance Stock Unit Awards (PSUs) [Member] \| 90th percentile relative TSR [Member] \| Maximum [Member]
Share-based compensation arrangement performance obligations, percentage					200.00%
2012 Plan [Member]
Number of equity incentive plans \| item					2
Number of shares authorized					123,175
Share-based compensation arrangement options outstanding					97,452
Share-based compensation arrangement options remain exercisable					97,327
2017 Plan [Member]
Share-based compensation arrangement by share-based payment award, number of additional shares authorized					325,000
Share-based compensation arrangement shares available for grant					383,848
2017 Plan [Member] \| Maximum [Member]
Number of shares authorized					226,626
Share-based compensation arrangement shares available for grant					551,626
2012 Equity Plan and 2017 Equity Plan [Member]
Share-based compensation arrangement options outstanding					98,084	106,163
Share-based compensation arrangement options remain exercisable					97,959
Share-based compensation arrangement shares excercised					675
2012 Equity Plan and 2017 Equity Plan [Member] \| Employee Stock Option [Member]
Share-based compensation arrangement term					10 years
2012 Equity Plan and 2017 Equity Plan [Member] \| Employee Stock Option [Member] \| Minimum [Member]
Share-based compensation vesting period					3 years
2012 Equity Plan and 2017 Equity Plan [Member] \| Employee Stock Option [Member] \| Maximum [Member]
Share-based compensation vesting period					5 years
2012 Equity Plan and 2017 Equity Plan [Member] \| Liquidity Options [Member]
Share-based compensation arrangement options outstanding					58,582	63,411
Share-based compensation arrangement options remain exercisable					58,582
Employee Stock Purchase Plan (ESPP) [Member]
Aggregate number of shares of common stock reserved for issuance and sale pursuant to the ESPP	100,000				86,416
Maximum annual contributions per employee (percent)	18.00%
Maximum share purchase cap per offering period	52
Maximum annual contributions amount per employee \| $	$ 12,500
Purchase price of common stock expressed as a percentage of its fair value	85.00%				85.00%
Employee Stock Purchase Plan (ESPP) [Member] \| Offering Period Under ESPP October 16, 2017 - December 31, 2018 [Member]
Share-based compensation shares granted			7,824
Employee Stock Purchase Plan (ESPP) [Member] \| Offering Period Under ESPP January 1, 2019 to June 30, 2019 [Member]
Share-based compensation shares granted		5,760

Share-Based Compensation (Summary of Stock Option Activity) (Details) - 2012 Equity Plan and 2017 Equity Plan [Member] - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Beginning balance, Outstanding (in shares)	106,163
Exercised (in shares)	(675)
Forfeited (in shares)	(1,259)
Expired (in shares)	(6,145)
Ending balance, Outstanding (in shares)	98,084	106,163
Unvested at end of period (in shares)	125
Exercisable at end of period (in shares)	97,959
Service Based Options [Member]
Beginning balance, Outstanding (in shares)	42,752
Beginning balance, Weighted average exercise price (in dollars per share)	$ 122.39
Exercised (in shares)	(675)
Exercised, Weighted average exercise price (in dollars per share)	$ 0.20
Forfeited (in shares)	(150)
Forfeited, Weighted average exercise price (in dollars per share)	$ 191.20
Expired (in shares)	(2,425)
Expired, Weighted average exercise price (in dollars per share)	$ 122.67
Ending balance, Outstanding (in shares)	39,502	42,752
Ending balance, Weighted average exercise price (in dollars per share)	$ 124.20	$ 122.39
Weighted average remaining contractual life (years)	2 years 1 month 10 days	3 years 2 months 19 days
Unvested at end of period (in shares)	125
Unvested at end of period, Weighted average exercise price (in dollars per share)	$ 193.40
Exercisable at end of period (in shares)	39,377
Exercisable at end of period, Weighted average exercise price (in dollars per share)	$ 123.98
Exercisable, Weighted average remaining contractual life (years)	2 years 1 month 10 days
Liquidity Options [Member]
Beginning balance, Outstanding (in shares)	63,411
Beginning balance, Weighted average exercise price (in dollars per share)	$ 123.14
Forfeited (in shares)	(1,109)
Forfeited, Weighted average exercise price (in dollars per share)	$ 149.99
Expired (in shares)	(3,720)
Expired, Weighted average exercise price (in dollars per share)	$ 147.69
Ending balance, Outstanding (in shares)	58,582	63,411
Ending balance, Weighted average exercise price (in dollars per share)	$ 121.07	$ 123.14
Weighted average remaining contractual life (years)	2 years 26 days	3 years 1 month 28 days
Exercisable at end of period (in shares)	58,582
Exercisable at end of period, Weighted average exercise price (in dollars per share)	$ 121.07
Exercisable, Weighted average remaining contractual life (years)	2 years 26 days

Share-Based Compensation (Summary of Stock Unit Awards Activity) (Details)	12 Months Ended
	Dec. 31, 2020 $ / shares shares
Restricted Stock Units (RSUs) [Member]
Beginning balance, Non-vested awards (in shares)	66,819
Granted (in shares)	25,047
Vested (including 4,371 shares that have not been released)	(30,401)
Forfeited (in shares)	(12,434)
Ending balance, Non-vested awards (in shares)	49,031
Beginning balance, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	$ 158.61
Granted, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	22.11
Vested, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	166.84
Forfeited, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	121.81
Ending balance, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	$ 93.11
Shares held in Employee Stock Option Plan, Suspense Shares	4,371
Equivalent Stock Unit Awards [Member]
Beginning balance, Non-vested awards (in shares)	28,790
Granted (in shares)	150,036
Vested (including 4,371 shares that have not been released)	(9,609)
Forfeited (in shares)	(34,425)
Ending balance, Non-vested awards (in shares)	134,792
Beginning balance, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	$ 110.21
Granted, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	21.71
Vested, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	110.21
Forfeited, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	36.58
Ending balance, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	$ 30.50
Performance Based Restricted Stock Units [Member]
Beginning balance, Non-vested awards (in shares)	26,684
Granted (in shares)	51,806
Forfeited (in shares)	(7,821)
Ending balance, Non-vested awards (in shares)	70,669
Beginning balance, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	$ 193.80
Granted, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	26.20
Forfeited, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	347.61
Ending balance, Non-vested awards weighted average grant date fair value (in dollars per share) \| $ / shares	$ 53.91

Share-Based Compensation (Schedule of Weighted Average Assumptions Used to Estimate Fair Value of Awards) (Details) - $ / shares	6 Months Ended	12 Months Ended			15 Months Ended
	Jun. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2018
February 28, 2020 [Member] \| Performance Stock Unit Awards (PSUs) [Member]
Grant date		Feb. 28, 2020
Performance period start date		Jan. 01, 2020
Performance period end date		Dec. 31, 2022
Expected volatility		70.70%
Average risk free interest rate		0.90%
Grant date price		$ 21.80
Weighted-average fair value per share		$ 26.20
February 28, 2019 [Member] \| Performance Stock Unit Awards (PSUs) [Member]
Grant date			Feb. 28, 2019
Performance period start date			Jan. 01, 2019
Performance period end date			Dec. 31, 2021
Expected volatility			63.20%
Average risk free interest rate			2.50%
Grant date price			$ 110.20
Weighted-average fair value per share			$ 130.00
March 1, 2018 [Member] \| Performance Stock Unit Awards (PSUs) [Member]
Grant date				Mar. 01, 2018
Performance period start date				Jan. 01, 2018
Performance period end date				Dec. 31, 2020
Expected volatility				54.30%
Average risk free interest rate				2.30%
Grant date price				$ 290.60	$ 290.60
Weighted-average fair value per share				347.40	$ 347.40
Employee Stock Purchase Plan (ESPP) [Member]
Expected volatility	82.80%				38.80%
Average risk free interest rate	2.50%				1.40%
Weighted-average fair value per share	$ 40.40			$ 143.20	$ 143.20

Share-Based Compensation (Summary of Share-Based Compensation Expense Recognized in Selling, General and Administrative Expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Total share-based compensation expense	$ 8,482	$ 12,542	$ 10,930
Related income tax benefit	92	157	1,698
Employee Stock Option [Member]
Total share-based compensation expense	1,459	5,263	5,865
Restricted Stock Units (RSUs) [Member]
Total share-based compensation expense	3,921	5,032	3,672
Equivalent Stock Units (ESUs) [Member]
Total share-based compensation expense	759	338
Performance Stock Unit Awards (PSUs) [Member]
Total share-based compensation expense	$ 2,343	1,682	800
Employee Stock Purchase Plan (ESPP) [Member]
Total share-based compensation expense		$ 227	$ 593

Employee Benefit Plan (Narrative) (Details) - 401(k) plan [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Employer matching contribution, percent of match	100.00%
Employer matching contribution, percent of employees' gross pay	3.00%
Employer discretionary matching contribution, percent of match	50.00%
Employer discretionary maximum matching contribution, percent of employee' gross pay	4.00%
Employer discretionary contribution amount	$ 0.6	$ 1.5	$ 1.3

Leases (Narrative) (Details)
$ in Thousands

1 Months Ended

12 Months Ended

May 31, 2020

USD ($)

item

Feb. 29, 2020

USD ($)

item

Dec. 31, 2020

USD ($)

Dec. 31, 2019

USD ($)

Dec. 31, 2018

USD ($)

Operating lease assets

$ 5,170

$ 5,071

Long-term asset

^[1]

5,851

3,379

Lease liability

4,442

1,436

Outstanding lease obligation

1,347

1,481

Proceeds from sale of vehicles

1,094

1,372

$ 399

Surrender of assets for sale and retirement of the related lease obligations

(798)

Additional operating leases not yet commenced

2,600

Operating lease expense

3,500

$ 3,800

$ 3,400

Retired Lease [Member] | Impact of COVID -19 [Member] | Vehicles [Member]

Long-term asset

1,200

Finance lease historical cost

3,100

Finance lease accumulated depreciation

1,900

Outstanding lease obligation

800

Proceeds from sale of vehicles

1,000

Surrender of assets for sale and retirement of the related lease obligations

$ 800

Maximum [Member]

Operating lease renewal terms

10 years

Minimum [Member]

Operating lease renewal terms

5 years

Houston, Texas [Member]

Operating lease assets

$ 2,400

Operating lease, term of contract

7 years 6 months

Operating lease term number of renewal options | item

Houston, Texas [Member] | Additional Lease Term [Member]

Operating lease renewal terms

5 years

Odessa, Texas [Member] | Land and Building [Member]

Long-term asset

$ 4,000

Lease liability

$ 4,000

Finance lease term of contract

10 years

Finance lease, renewal term

5 years

Finance lease term number of renewals | item

[1]	Finance lease right-of-use assets are recorded net of accumulated amortization of $2.2 million and $2.4 million as of December 31, 2020 and 2019, respectively.

Leases (Supplemental Balance Sheet Information Related to Leases) (Details) - USD ($)
$ in Thousands

Dec. 31, 2020

Dec. 31, 2019

Operating lease right-of-use assets

$ 5,170

$ 5,071

Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]

Operating lease right-of-use assets

Finance lease right-of-use assets

^[1]

$ 5,851

$ 3,379

Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]

Property, Plant and Equipment, Net

Total leased right-of-use assets

$ 11,021

$ 8,450

Liabilities Current

Operating lease liabilities

$ 1,826

$ 2,052

Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]

Operating lease liabilities

Finance lease liabilities

$ 1,347

$ 1,481

Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]

Long-term Debt, Current Maturities

Liabilities Noncurrent

Operating lease liabilities

$ 3,989

$ 3,487

Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]

Operating lease liabilities

Finance lease liabilities

$ 4,442

$ 1,436

Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]

Long-term Debt, Excluding Current Maturities

Total lease liabilities

$ 11,604

$ 8,456

Finance Lease Right Of Use Assets [Member]

Liabilities Noncurrent

Finance lease accumulated depreciation

$ 2,200

$ 2,400

[1]	Finance lease right-of-use assets are recorded net of accumulated amortization of $2.2 million and $2.4 million as of December 31, 2020 and 2019, respectively.

Leases (Components of Lease Expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease cost	$ 2,193	$ 2,891
Finance lease cost
Amortization of right-of-use assets	1,503	1,409
Interest on lease liabilities	300	257
Short-term lease cost	1,280	898
Total lease cost	$ 5,276	$ 5,455

Leases (Maturities of Lease Liabilities) (Details) $ in Thousands	Dec. 31, 2020 USD ($)
Operating Leases
2021	$ 2,074
2022	1,335
2023	837
2024	744
2025	613
Thereafter	930
Total lease payments	6,533
Less: interest	718
Present value of lease liabilities	5,815
Finance Leases
2021	1,597
2022	1,274
2023	742
2024	493
2025	492
Thereafter	2,182
Total lease payments	6,780
Less: interest	991
Present value of lease liabilities	$ 5,789

Leases (Lease Term and Discount Rate) (Details)	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Weighted-average remaining lease term (years): Operating leases	4 years 1 month 6 days	2 years 10 months 24 days
Weighted-average remaining lease term (years): Finance leases	7 years 2 months 12 days	1 year 7 months 6 days
Weighted-average discount rate: Operating leases	5.40%	5.90%
Weighted-average discount rate: Finance leases	4.90%	5.50%

Leases (Supplemental Cash Flow and Other Information Related to Leases) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Cash paid for amounts included in measurement of lease liabilities: Operating cash flows from operating leases	$ 2,324	$ 3,278
Cash paid for amounts included in measurement of lease liabilities: Operating cash flows from finance leases	300	257
Cash paid for amounts included in measurement of lease liabilities: Financing cash flows from finance leases	$ 1,634	$ 1,705

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax Contingency [Line Items]
Income tax (benefit) expense	$ (7,783)	$ 10,752	$ (23,052)
Effective tax rate	16.60%	(89.10%)	11.10%
Deferred tax assets, valuation allowance	$ 22,312	$ 14,226
Domestic Tax Authority [Member]
Income Tax Contingency [Line Items]
Deferred tax assets, valuation allowance	20,700	14,200
Foreign Tax Authority [Member]
Income Tax Contingency [Line Items]
Deferred tax assets, valuation allowance	1,400
Net Operating Loss Carryback [Member] \| Domestic Tax Authority [Member]
Income Tax Contingency [Line Items]
Income tax (benefit) expense	(900)
Increase In Valuation Allowance On Deferred Tax Assets [Member]
Income Tax Contingency [Line Items]
Income tax (benefit) expense	6,500
Valuation Allowance Against Canadian Deferred Tax Assets [Member] \| Foreign Tax Authority [Member]
Income Tax Contingency [Line Items]
Income tax (benefit) expense	1,400
Reduction In Foreign Tax Expense [Member] \| Domestic Tax Authority [Member]
Income Tax Contingency [Line Items]
Income tax (benefit) expense	$ (1,500)
Valuation Allowance Against U.S. Deferred Tax Assets [Member]
Income Tax Contingency [Line Items]
Income tax (benefit) expense		$ 13,100
Impairment Charge [Member] \| Domestic Tax Authority [Member]
Income Tax Contingency [Line Items]
Income tax (benefit) expense			$ 32,800

Income Taxes (Provision (Benefit) from Income Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Current tax expense (benefit):
U.S. Federal	$ (413)	$ (382)	$ 1,241
State	(183)	221	240
Foreign	(3,985)	1,913	4,307
Total current	(4,581)	1,752	5,788
Deferred tax expense (benefit):
U.S. Federal		8,746	(9,525)
State		580	(599)
Foreign	(3,202)	(326)	(18,716)
Total deferred	(3,202)	9,000	(28,840)
Total income taxes	$ (7,783)	$ 10,752	$ (23,052)

Income Taxes (Domestic and Foreign Components of (Loss) Income Before Income Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Taxes [Abstract]
U.S. Federal	$ (25,086)	$ (13,762)	$ (52,523)
Foreign	(21,803)	1,696	(155,760)
Loss before income tax	$ (46,889)	$ (12,066)	$ (208,283)

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Less: income attributable to non-controlling interest

Income Taxes (Summary of Items that Caused Recorded Income Taxes to Differ from Income Taxes Computed Using Statutory Federal Income Tax Rate) (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Taxes [Abstract]
Income tax at federal statutory rate	21.00%	21.00%	21.00%
Impairment expense		(2.60%)	(15.70%)
Foreign taxes on U.S. income	2.60%	(12.10%)
Non-controlling interest gain/losses	6.70%	15.70%	0.50%
U.S. tax on foreign earnings	(1.70%)	(5.70%)	1.50%
Nondeductible expenses	1.20%	(3.70%)	(0.20%)
Deductible foreign taxes	(0.10%)	2.70%
Non U.S. income taxed at different rates	3.20%	(1.20%)	4.50%
Research and other tax credits	0.90%	6.40%	0.40%
Effect of rate change on deferred tax	(0.70%)	1.90%
Stock-based compensation	(2.20%)	(7.70%)	(0.20%)
State taxes	1.10%	4.10%	0.20%
Change in valuation allowance	(16.90%)	(108.60%)	(0.50%)
Other	1.50%	0.70%	(0.40%)
Income tax	16.60%	(89.10%)	11.10%

Income Taxes (Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Deferred tax assets:
Accruals not currently deductible	$ 6,579	$ 6,076
Depreciation and amortization	12,019	5,097
Foreign tax credit carryforward		778
Tax credit carryforwards	1,284	269
Other	2,735	2,074
Total deferred tax assets, gross	22,617	14,294
Valuation allowance for deferred tax assets	(22,312)	(14,226)
Total deferred tax assets	305	68
Deferred tax liabilities:
Depreciation and amortization		(3,006)
Foreign currency translation	(78)	(7)
Other	(35)	(5)
Total deferred tax liabilities	(113)	(3,018)
Net deferred tax liabilities		(2,950)
Net deferred tax assets	192
Deferred income tax assets—noncurrent	205	6
Deferred income tax liabilities—noncurrent	$ (13)	$ (2,956)

Loss Per Share (Reconciliation of Numerator and Denominator for Calculating (loss) Earnings Per Share from Net (loss) Income) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Dec. 31, 2019

Sep. 30, 2019

Jun. 30, 2019

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Dec. 31, 2018

Numerator—Basic

Net loss

$ 23,830

$ (5,137)

$ (8,892)

$ (48,907)

$ 19

$ 6,609

$ (19,568)

$ (9,878)

$ (39,106)

$ (22,818)

$ (185,231)

18,493

10,005

5,086

Net loss attributable to NCS Multistage Holdings, Inc.

$ 8,570

$ (5,863)

$ (8,757)

$ (51,549)

$ (2,177)

$ 3,621

$ (22,301)

$ (11,966)

$ (57,599)

$ (32,823)

$ (190,317)

Denominator

Basic weighted average number of shares (in shares)

^[1]

2,364

2,332

2,239

Diluted weighted average number of shares (in shares)

^[1]

2,364

2,332

2,239

Loss per common share

Basic (in dollars per share)

$ 3.62

^[2]

$ (2.48)

^[2]

$ (3.70)

^[2]

$ (21.92)

^[2]

$ (0.93)

^[2]

$ 1.54

^[2]

$ (9.54)

^[2]

$ (5.20)

^[2]

$ (24.37)

^[1]

$ (14.08)

^[1]

$ (85.00)

^[1]

Diluted (in dollars per share)

$ 3.59

^[2]

$ (2.48)

^[2]

$ (3.70)

^[2]

$ (21.92)

^[2]

$ (0.93)

^[2]

$ 1.54

^[2]

$ (9.54)

^[2]

$ (5.20)

^[2]

$ (24.37)

^[1]

$ (14.08)

^[1]

$ (85.00)

^[1]

Potentially dilutive securities excluded as anti-dilutive

^[1]

221

213

178

Reverse stock split, description

1-for-20

[1]

Amounts in 2019 and 2018 have been retrospectively adjusted for the 1-for-20 reverse stock split that was effective on December 1, 2020.

[2]

Segment and Geographic Information (Narrative) (Details)	12 Months Ended
	Dec. 31, 2020 segment
Segment and Geographic Information [Abstract]
Number of reportable segments	1

Segment and Geographic Information (Summary of Revenue and Long-Lived Assets by Geographical Area) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenue and Long-Lived Assets by Country [Line Items]
Revenue	$ 27,383	$ 16,312	$ 8,732	$ 54,550	$ 52,094	$ 60,773	$ 39,768	$ 52,850	$ 106,977	$ 205,485	$ 226,963
Long-lived assets	29,605				38,045				29,605	38,045
Product sales [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									75,197	145,826	156,781
Services [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									31,780	59,659	70,182
United States [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									46,179	103,291	103,442
Long-lived assets	16,616				18,137				16,616	18,137
United States [Member] \| Product sales [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									38,866	79,128	67,458
United States [Member] \| Services [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									7,313	24,163	35,984
Canada [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									48,549	86,563	109,478
Long-lived assets	10,356				17,831				10,356	17,831
Canada [Member] \| Product sales [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									34,330	59,895	80,871
Canada [Member] \| Services [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									14,219	26,668	28,607
Other Countries [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									12,249	15,631	14,043
Long-lived assets	$ 2,633				$ 2,077				2,633	2,077
Other Countries [Member] \| Product sales [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									2,001	6,803	8,452
Other Countries [Member] \| Services [Member]
Revenue and Long-Lived Assets by Country [Line Items]
Revenue									$ 10,248	$ 8,828	$ 5,591

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Quarterly Financial Data (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Dec. 31, 2019

Sep. 30, 2019

Jun. 30, 2019

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Dec. 31, 2018

Quarterly Financial Data [Abstract]

Income (loss) from operations

$ 27,383

$ 16,312

$ 8,732

$ 54,550

$ 52,094

$ 60,773

$ 39,768

$ 52,850

$ 106,977

$ 205,485

$ 226,963

Cost of sales

15,692

10,208

6,393

30,614

25,977

32,209

23,081

26,763

62,907

108,030

108,306

Gross profit

^[1]

11,121

5,595

1,695

22,937

25,106

27,562

15,671

25,139

Impairments

50,194

7,919

50,194

7,919

227,543

(57)

(7,473)

(14,232)

(49,678)

1,320

5,509

(16,757)

437

(71,440)

(9,491)

(206,664)

Gain on patent infringement settlement

25,678